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ABSTRACT 
Approximately 30-50% of colorectal cancers contain KRas mutations, which 
confer resistance to standard therapy.  A diet high in long-chain n-3 polyunsaturated 
fatty acids (n-3 PUFA) is generally considered chemoprotective in regard to colon 
cancer.  However, the molecular mechanisms by which n-3 PUFA suppresses 
tumorigenesis remain to be determined.  Therefore, our overall goal is to define the role 
of n-3 PUFA in the modulation of oncogenic KRas-driven colon cancer.  
We hypothesized that n-3 PUFA would modify the biophysical properties of the 
plasma membrane though its incorporation into plasma membrane phospholipids.  
Utilizing quantitative fluorescence microscopy, we determined that n-3 PUFA reduce the 
rigidity of the plasma membrane of young adult mouse colonocytes (YAMC), 
CD3/CD28 activated CD4+ T cells, and colonic crypts derived from transgenic Fat-1 
mice, which synthesize n-3 PUFA de novo.  Interestingly, n-3 PUFA increased the 
rigidity of cytoskeletal free giant plasma membrane vesicles (GPMVs), derived from the 
aforementioned samples. 
Oncogenic Ras signaling is dependent on the formation of specific plasma 
membrane localized proteolipid complexes. Thus, it is noteworthy in YAMC cells and 
Drosophila midguts we documented for the first time that n-3 PUFA generates mix 
clusters of H- and K-Ras isoforms, which signal through ERK less efficiently. This 
resulted in a reduction of Ras driven colonic phenotypes in mice and Drosophila models. 
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We then assessed the ability of n-3 PUFA to disrupt macropinocytosis, a cellular 
process in which extra cellular proteins are internalized through dynamic changes in 
plasma membrane lipids and cytoskeletal proteins.  This process provides energy 
substrates that support the unique metabolic needs of Ras expressing cells. We 
determined that Ras expression mediates an increase in plasma membrane free 
cholesterol, which rigidifies the plasma membrane. Attenuating this rigidification by 
incorporating n-3 PUFA into the plasma membrane disrupted Ras driven 
macropinocytosis.  
 Overall, we have demonstrated that n-3 PUFA ameliorate oncogenic Ras driven 
phenotypes through modification of plasma membrane biophysical properties leading to 
a disruption of Ras signaling.  This reduces the ability of tumor cells to acquire energy 
substrate necessary to maintain its unique metabolic needs. These data contribute to the 
mechanistic understanding of how n-3 PUFA protect against colon cancer.  
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 CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
1.1 Risk for Colorectal Cancer (CRC) 
 CRC is the third most common type of cancer in the U.S. and is estimated to 
account for roughly 9% of new cancer cases and 9% of cancer deaths in 2017 (Siegel et 
al., 2017).  Overall, CRC incidence and mortality rates have decreased in the past 20 
years, attributed largely to use of CRC screening and polypectomy in adults over 50 
years. However, among adults younger than 50 years, for whom screening is not 
recommended if at average risk, CRC incidence rates have been increasing by ~2% per 
year since 1994 in both men and women (American Cancer Society, 2015). While 
genetic factors account for some of the CRC risk, environmental factors, such as diet, 
obesity, tobacco use, or environmental pollutants, account for the majority of risk 
(Coussens et al., 2013).  
 
1.2 n-3 PUFA and CRC  
CRC risk could be greatly reduced through dietary modification, including 
increased dietary fiber intake and reduced fat intake (Vargas and Thompson, 2012). The 
long-chain PUFA, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are 
found in fish oils (Strobel et al., 2012). In general, n-6 PUFA are considered pro-
inflammatory whereas n-3 PUFA are considered anti-inflammatory (Chapkin et al., 
2009; Spite et al., 2014). Given the strong association between inflammation and CRC 
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(Elinav et al., 2013), higher intakes of n-3 PUFA provide biological plausibility for a 
chemoprotective effect (Chapkin et al., 2007; Cockbain et al., 2012). Research using 
preclinical models consistently show reduced CRC risk with n-3 PUFA (Chang et al., 
1997; Chapkin et al., 2008a; Piazzi et al., 2014; Reddy et al., 1991, 2005); however, 
epidemiologic data are inconsistent and the majority of studies did not include PUFA 
intake from supplemental fish oil (Beresford et al., 2006; Gerber, 2012; Henderson, 
1992; Prentice and Sheppard, 1990; Watson and Collins, 2011). Two meta-analyses have 
concluded that fish intake is associated with decreased risk of CRC (Pot et al., 2009; Wu 
et al., 2012); however, two systematic reviews of n-3 PUFA on cancer risk qualitatively 
concluded that there is inadequate (MacLean et al., 2006) or limited (Gerber, 2012) 
evidence to suggest an association between long-chain n-3 PUFA intake and CRC risk. 
In contrast to the epidemiologic literature, in an endoscopy-based case-control study on 
colorectal adenomas, serum n-3 PUFA were inversely associated with colorectal 
adenoma risk (0.67; 95% CI: 0.46, 0.96) (Pot et al., 2008). Recently, in the VITamins 
And Lifestyle (VITAL) cohort, it was noted that persons using fish oil supplements on 
4+ days/wk for 3+yr experienced 49% lower CRC risk than nonusers (hazard ratio = 
0.51, 95% CI = 0.26–1.00; P trend = 0.06) (Kantor et al., 2014). Interestingly, the same 
study showed no association of dark fish and total EPA + DHA intake with CRC risk 
overall (Kantor et al., 2014).  
With respect to clinical studies, mounting evidence suggests that the 
consumption of fish oil may reduce colon cancer risk in humans (Anti et al., 1992, 1994; 
Bartram et al., 1993; Caygill et al., 1996; Cheng et al., 2003; Courtney et al., 2007; Hall 
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et al., 2008).  EPA and DHA appear to be ideally suited to work either alone or in 
combination with chemoprotective drugs (Vaughan et al., 2013), e.g., NSAIDs, whose 
long-term use is contraindicated (Baron et al., 2008; Graham, 2006). Recently, it was 
demonstrated that EPA reduced rectal polyp number and size in patients with familial 
adenomatous polyposis (FAP) (Cockbain et al., 2012; West et al., 2010).  Most 
impressive was the fact that fish oil derived n-3 PUFA suppressed FAP to a degree 
similar to the selective COX-2 inhibitor celecoxib.  Ongoing clinical trials (Clinical 
Trials.gov) are currently examining the effects of EPA on subjects at high risk of CRC 
(NCT02069561); the combinatory role of EPA and DHA in reducing rectal cancer risk 
(NCT02534389), and the combinatory role of EPA and NSAIDs on polyp recurrence in 
the colon (NCT01070355; ISRCTN05926847) (Cockbain et al., 2014; Hull et al., 2013).  
Collectively, these data indicate that n-3 PUFA hold promise as chemoprevention 
agents. 
 
1.3 Cellular lipid classes 
 Lipids can be divided into the following classes: (1) fatty acids (FAs) that mainly 
serve as intermediates in lipid biosynthesis; (2) free sterols, e.g., cholesterol, that serve 
as structural components in membranes; (3) sterol esters that are formed from FAs and 
sterols and serve as lipid storage compounds, mainly as lipid bodies; (4) triacylglycerols 
(TAG) that are formed from glycerol and FAs that serve as lipid storage, mainly in lipid 
bodies; (5) phospholipids/phosphoglycerides (PLs) that are formed from FAs, glycerol 
and an alcohol moiety, e.g., inositol, choline or ethanolamine, that serve as structural 
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components of membranes; and (6) sphingolipids that contain a sphingosine backbone 
and a very long chain FA.  These phospholipids serve as structural components of cell 
membranes as well as play key signaling roles, e.g., regulation of endocytosis, ubiquitin 
dependent proteolysis and cell cycle control (Nielsen, 2009; Rohrig and Schulze, 2016).  
Despite the large chemical variety of lipids, they all have the same key carbon precursor, 
namely acetyl-CoA, and all initial steps of lipid/cholesterol biosynthesis occur in the 
cytosol (Rohrig and Schulze, 2016).  As illustrated in Figure 1.1, lipid biosynthesis 
involves two branches from acetyl-CoA, one leading to sterols and the other leading to 
Figure 1.1. Synthesis of cellular lipids.  Fatty acid building blocks are derived from 
exogenous and endogenous (de novo) sources. 
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FAs that serve as building blocks for biosynthesis of TAG, phospholipids, sterol esters 
and sphingolipids.  
 
1.4 Composition of cellular membranes 
 Eukaryotic cells contain different types of membranes, including the plasma, 
endosomal, nuclear and mitochondrial membranes.  The specific lipid composition of 
these membranes influences function, and since these membranes carry out vastly 
different functions, inherently their composition is extremely diverse (Spector and 
Yorek, 1985). Their heterogeneous composition is the result of de novo lipid synthesis 
(Kennedy pathway), exogenous substrate availability (Lands’ cycle) and vesicular 
trafficking events (Spector and Yorek, 1985).  Unlike proteins that are directly encoded 
in the genome, lipid composition is the result of an indirect influence of biosynthetic 
enzymes and exogenous substrate availability.   
 
1.5 Structural and cellular function of membrane cholesterol  
 Cholesterol is an essential component of higher eukaryotic membranes and plays 
an important role in cell membrane organization, dynamics and function (Bloch, 1983). 
It is the end product of a sterol biosynthetic pathway involving more than 20 enzymes 
(Singh et al., 2013).  According to the ‘Bloch hypothesis’, the sterol biosynthetic 
pathway parallels sterol evolution. In other words, the cholesterol biosynthetic pathway 
has evolved by the process of natural selection to optimize properties of eukaryotic cell 
membranes for specific biological functions (Hedlund et al., 2011). As an important 
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membrane component, cholesterol helps to generate a semi-permeable barrier between 
cellular compartments and to regulate membrane fluidity.  Cholesterol favors the 
formation of highly packed and ordered rigid domains.  A common term used for the 
ordered domains is “lipid-rafts” (Levental and Veatch, 2016; Sezgin et al., 2017).  From 
a functional perspective, the cholesterol / phospholipid composition of cellular 
membranes is known to influence lipid raft formation and the ability of plasma 
membrane receptors / signaling proteins to function properly (Griffié et al., 2015; Hou et 
al., 2016; Phillips et al., 2009). 
 
1.6       Plasma membrane nanoclusters and fluidity  
The plasma membrane is composed of a heterogeneous mixture of 
lipids/cholesterol and proteins whose distinct organization maintains efficient signal 
transduction.  Lipid rafts, enriched in sphingolipids, cholesterol and associated proteins, 
are special plasma membrane microdomains with an increased structural order, and are 
designated liquid ordered domains of plasma membranes (Sezgin et al., 2017). These 
lipid rafts are believed to be dynamic and small (5–200 nm) membrane microdomains, 
which play a critical role as sorting platforms for many membrane-associated proteins 
(Frisz et al., 2013; Hancock, 2006; Kraft, 2013; Levental and Veatch, 2016; Lingwood 
and Simons, 2010).  Importantly, these domains are generally below the resolution of 
light microscopy (~200 nm).  However, using techniques like fluorescence lifetime 
imaging microscopy combined with fluorescence resonance energy transfer (FLIM-
FRET) or photo-activated localization microscopy (PALM), it is now possible to 
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directly observe nanoscale dynamics of membrane lipids in living cells (Eggeling et al., 
2009; Sahl et al., 2014).  For example, the increased accessibility of super-resolution 
microscopy techniques has shed new light on the nanoscale organization of membrane 
proteins (Sezgin, 2017; Wang et al., 2014).  
 According to the emerging membrane biology picture, protein and lipid 
nanoclusters can be organized to form domains that are capable of facilitating signaling 
events (Ariotti et al., 2014; Garcia-Parajo et al., 2014; Zhou and Hancock, 2015).  The 
formation of these nanoclusters is believed to be driven by cortical actin and/or proximal 
transmembrane proteins (Garcia-Parajo et al., 2014).  Currently, protein-protein, lipid-
lipid and protein-lipid nanoclusters are considered a predominant feature of the plasma 
membrane and appear to mediate critical signaling processes (Ariotti et al., 2014), 
including signal integration and cross talk of the transduction of oncogenic Ras and the 
epidermal growth factor receptor (EGFR) (Ariotti et al., 2014; Janosi et al., 2012; Zhou 
et al., 2012) regulated pathways. This is noteworthy, because there is emerging evidence 
that drugs and select membrane active dietary components, which we term membrane 
targeted dietary bioactives (MTDBs), e.g., n-3 PUFA, can attenuate Ras and EGFR 
(Ariotti et al., 2014; Chapkin et al., 2008b; Nussinov et al., 2014) activity by modulating 
nanocluster organization. It also has been suggested that disrupting 
clustering/dimerization of membrane associated proteins can lead to attenuation of 
downstream oncogenic signaling and the suppression of tumor growth (Fuentes et al., 
2017).  
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Approximately 90% of cellular cholesterol  resides in the plasma membrane 
(Kim et al., 1991; Lange et al., 1989; Ueland et al., 1986), and increases in cholesterol 
promote plasma membrane order (Montero et al., 2008).  This is significant, because 
highly ordered/rigid lipid rafts are increased in many types of cancer (Li et al., 2006; 
Patra, 2008) and some multidrug-resistant cancers (Yang et al., 2009; Yi et al., 2013).  
The term ‘rigidity’ refers to the packing of the lipids in the membrane, and cholesterol 
favors the production of more tightly pack “rigid” domains. This increased rigidity 
associated with increased lipid rafts typically facilitates efficient cellular signaling.  
Interestingly, multidrug-resistant cells have remodelled their membranes to be in a state 
that is more rigid and thus receptive to activation (Li et al., 2015; Raghavan et al., 2015).  
This increase in rigidity, may explain why lung cancer cells have more clustered and 
highly activated epidermal growth factor receptor (EGFR), compared to normal lung 
epithelium (Wang et al., 2014).   
 There is evidence suggesting that disruption of lipid rafts in cancer can lead to 
increased responsiveness to anti-cancer therapies (Fedida-Metula et al., 2012; Irwin et 
al., 2011).  Additionally, some anti-cancer drugs have beneficial effects through 
alteration of the protein content of lipid rafts (George and Wu, 2012; Hryniewicz-
Jankowska et al., 2014).  In colon cancer, lipid rafts have been shown to function in cell 
death (apoptosis)-mediated signaling (Lacour et al., 2004; Rebillard et al., 2007), cell 
entry/bioavailability of bioactive compounds (Adachi et al., 2007) and localization of 
key proteins involved in immune response (Bene et al., 2004).  These findings indicate 
that lipids can no longer be ignored in the structures of membrane complexes, due to 
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their ability to fine-tune and stabilize different signaling interfaces (Barrera et al., 2013; 
Levental et al., 2016; Lin et al., 2016).  For several viruses linked to cancer risk, a 
dependence on cholesterol for virus entry and/or morphogenesis has also been shown. 
Cholesterol depletion of virus-infected cells affects integrity of the virus envelope, 
causes disruption of the viral envelope and adversely affects virus infectivity (Barman 
and Nayak, 2007; Imhoff et al., 2007).  For this reason, there is considerable interest in 
identifying alternative strategies for lowering cholesterol, micronutrient supplementation 
and pharmaceutical development.   
 
1.7 Impact of dietary fatty acids on plasma membrane composition and 
structure 
 Diet can play an impactful role in modifying the plasma membrane. The idea that 
dietary lipids can influence membrane structure is intuitive, since the plasma membrane 
itself is composed of phospholipids.  Phospholipids are amphiphilic molecules composed 
of two hydrophobic fatty acid tails and a hydrophilic head.  In general, dietary lipids are 
transported as circulating lipoproteins containing triglycerides and phospholipids. Cells 
subsequently take up circulating lipids and use them for energy or the synthesis and 
remodeling of membranes.  Animal and plant fats and oils are composed of fatty acids of 
different chain lengths (14-24 carbons), which contain different amounts of unsaturation 
(1-6 double bonds). Not only the chain length and amount of unsaturation, but also the 
position of the double bonds in relation to the methyl end of the FA (n-9 vs n-6 vs n-3) 
impact its biophysical properties.  Mammalian cells can endogenously produce most 
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fatty acids, however, they lack the desaturase enzymes necessary to produce n-6 or n-3 
fatty acids de novo (Chapkin, 2007).  Therefore, these lipids must be obtained via the 
diet and are considered essential. For example, linoleic acid (LA), an n-6 PUFA is highly 
enriched in a common staple of the western-diet, corn oil. In comparison, n-3 PUFA, 
e.g., alpha-linoleic acid (ALA), eicosapentaenoic acid (EPA, 20:5Δ5,8,11,14,17) and 
docosahexaenoic acid (DHA, 22:6Δ4,7,10,13,16,19), are less prevalent in the western-diet. 
With respect to the molecular mechanism of n-3 PUFA action, there is a growing 
body of in vitro and in vivo evidence indicating that n-3 PUFA reshape plasma 
membrane domains.  For example, EPA and DHA, whose membrane phospholipid 
levels are readily influenced by diet in general (Katan et al., 1997), are rapidly 
incorporated into cells, primarily into membrane phospholipids at the sn-2 position 
(Figure 1.2) (Chapkin et al., 1991; Hou et al., 2016; Williams et al., 2012). The presence 
of long chain n-3 PUFA in membrane phospholipids imparts unique biophysical 
properties which have been linked to alterations in plasma membrane structure and 
function (Levental et al., 2016; Ma et al., 2004b; Seo et al., 2006; Williams et al., 2012).  
For example, DHA is known to influence membrane fluidity, ion permeability, fatty acid 
exchange, and resident protein function (Hou et al., 2015, 2016; Stillwell and Wassall, 
2003), including the inhibition of epidermal growth factor receptor (EGFR)  signaling in 
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tumor bearing mice by disassociating EGFR from lipid rafts (Turk et al., 2012). 
Interestingly, n-3 PUFA are also known to modulate differences in membrane rigidity 
between raft and non-raft domains (Levental et al., 2016; Lin et al., 2016), likely driven 
by repulsive forces between n-3 PUFA and cholesterol (Wang et al., 2017).  From a 
systemic perspective, membrane order is also increased in T cell plasma membranes 
from fish oil fed mice or transgenic mice that produce n-3 PUFA (Kim et al., 2008, 
2014).  Similarly, B cells isolated from mice fed n-3 PUFA-enriched diet exhibit an 
increase in membrane order in cross-linked cells relative to non-cross-linked (Rockett et 
Figure 1.2. Pathway involved with enrichment of dietary n-3 PUFA into cellular 
plasma membranes. Polyunsaturated fatty acids are delivered to colonocytes and 
other cells types, such as T-cells, through the bloodstream after digestion and 
absorption from the small intestine into the portal vein. Once in the cell the n-3 
PUFA are esterified to phospholipids. Abbreviation: DHA, docosahexaenoic acid 
reprinted from (Hou et al., 2016).  
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al., 2012).  This is in contrast to the decrease in membrane order reported in Jurkat cells 
treated with EPA and DHA (Kim et al., 2010; Zech et al., 2009).  A possible explanation 
for the differences reported in these studies is that malignant transformed Jurkat cell 
lines may be inherently distinct from primary T-cells with respect to specific plasma 
membrane properties. Precisely how these diet modulated changes in cell membrane 
order influence cell function remains to be determined. 
 Diet can also impact plasma membrane structure in a less intuitive manner. 
Specifically, many foods contain amphiphilic molecules that can directly interact with 
the plasma membrane (Fuentes et al., 2017).  For example, turmeric (Curcuma longa 
Linn) extracts, including curcumin (diferuloylmethane), a yellow color pigment of 
turmeric, inserts deep into the membrane in a trans-bilayer orientation, anchored by 
hydrogen bonding to the phosphate group of lipids in a manner analogous to cholesterol 
(Hung et al., 2008; Ingolfsson et al., 2007).  The combinatorial membrane interactions of 
n-3 PUFA and curcumin may explain the beneficial synergism observed in various 
studies (Altenburg et al., 2011; Kim et al., 2016; Saw et al., 2010; Siddiqui et al., 2013).  
 
1.8 A novel role for MTDB’s in modulating oncogenic KRas   
Ras proteins are GTPases, which are targeted to the membrane by farnesylation 
coupled to either palmitoylation, N, H and K(A), or a polybasic motif, K(B) (Eisenberg 
et al., 2013).  Approximately 30-50% of colorectal cancers contain KRas mutations, 
which confer resistance to standard therapy (Stephen et al., 2014), thereby reducing 
survival (Phipps et al., 2013).  Unfortunately, attempts to directly target Ras have 
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repeatedly failed (Phipps et al., 2013).  Ras proteins are important mediators of cell 
signaling.  There are a large number of Ras effector proteins, notably Raf (MAP kinase 
pathway), PI3K (Akt/mTOR pathway), and RalGDS (Ral pathway). These effectors are 
highly complex with numerous redundancies and interactions between pathways 
(Downward, 2003). Dysregulated (oncogenic) Ras signaling results in increased 
proliferation, decreased apoptosis, disrupted cellular metabolism and increased 
angiogenesis, all seminal hallmarks of cancer (Downward, 2003; Vasan et al., 2014).  
Since no curative treatments for KRas driven colon cancer are available, there is a 
critical need to develop toxicologically innocuous KRas therapeutic approaches that are 
free of safety problems intrinsic to drugs administered over long periods of time.  High 
efficiency signaling of KRas is dependent on its spatial organization into defined 
nanoclusters in inner leaflet of the plasma membrane (Tian et al., 2007).  Recently, it 
was demonstrated that select amphiphilic agents, through direct modulation of the 
biophysical properties of the plasma membrane, compromise oncogenic KRas 
nanoclustering to modulate signal transduction (Zhou and Hancock, 2015; Zhou et al., 
2012).  These findings suggest that Ras nanoclusters could be a novel new therapeutic 
target (Cho and Hancock, 2013).  This is consistent with a growing body of evidence 
indicating that n-3 PUFA suppress oncogenic Ras signaling (Collett et al., 2001; Ma et 
al., 2004b; Rogers et al., 2010; Seo et al., 2006; Turk et al., 2012). 
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1.9 Ras-dependent macropinocytosis 
Macropinocytosis is the cellular process in which membrane ruffling leads to the 
engulfment of extracellular components driven by dynamic changes in plasma 
membrane lipids and cytoskeletal proteins (Bohdanowicz and Grinstein, 2013; Levin et 
al., 2015; Lim and Gleeson, 2011).  Recently, macropinocytosis has been identified as a 
dependency of “undruggable”  Ras driven cancers, and is being targeted as an alternate 
strategy for cancer therapy (Commisso et al., 2013; Salloum et al., 2014). Plasma 
membrane components such as cholesterol (Grimmer et al., 2002) are required for 
membrane ruffling. Furthermore, phosphoinositide signaling (Maekawa et al., 2014) 
linked to Rac1 activation (Fujii et al., 2013) underlies the action of membrane ruffling 
which is essential for macropinocytosis. The effects of cholesterol depletion on Rac1 
activation vary (Grimmer et al., 2002; Iliev et al., 2007), however, macropinocytosis is 
consistently inhibited. This is likely a result of altering Rac1 membrane location 
(Grimmer et al., 2002) and lateral organization into specific membrane domains 
(Moissoglu et al., 2014).  The ability of Rac1 to stabilize cytoskeletal mesh networks 
ultimately influences the organization of the plasma membrane (Navarro-Lérida et al., 
2012). Similarly, cholesterol plays a crucial role in stabilizing membrane organization 
(Lingwood and Simons, 2010) and cytoskeletal connections (Kwik et al., 2003).  
However, precisely how the cytoskeleton and membrane interact to mediate 
macropinocytosis remains to be determined.  Thus, we seek to determine how MTDB’s 
that alter plasma membrane organization in a cytoskeletal-dependent process attenuate 
macropinocytosis.   
15 
1.10 Clinical impact of n-3 PUFA 
There are more than 550 clinical trials registered in the ClinicalTrials.gov 
investigating the effect of fish oil on various chronic diseases, implying the potential 
clinical impact of n-3 PUFA in human health.  For example, EPA (2 g/d for 3 mo) has 
been shown to reduce colonic crypt cell proliferation and increase apoptosis in normal 
colonic mucosa in subjects with a history of colorectal adenomas (Courtney et al., 2007).  
No tolerable upper limit has been set for EPA and DHA, although the US Food and Drug 
Administration recognizes doses of up to 3 g/day as safe and the European Safety Union 
up to 5 g/day as safe (Azzi et al., 2005).  Side effects of fish oil supplements or EPA + 
DHA ethyl esters include fishy burps, dyspepsia, gas, and diarrhea (Browning et al., 
2012; Yates et al., 2014).  Importantly, human studies using doses as high as 17.6 g/day 
EPA+DHA have been performed with no serious side effects (Skarke et al., 2015). n-3 
PUFA emulsion-based parenteral nutrition alleviates the inflammatory reactions and 
reduces the rate of inflammatory complications for patients recovering from surgical 
resection of gastric tumors (Wei et al., 2014).  EPA is incorporated rapidly 
into colonic mucosa and the colonic muscular layer in patients given 3 g of n-3 PUFA 
daily for 7 days before surgery for colorectal cancer (Sorensen et al., 2014), which 
supports claims related to the clinical benefits of n-3 PUFA.  Additional clinical studies 
are needed to assess the effect of EPA and/or DHA dose and duration on key molecular 
targets, e.g., cell plasma membranes, and related phenotypic outcomes. 
 16 
 
1.11 Summary of research goals   
Establishing a causal role for cancer dietary chemoprevention approaches that are 
generally free of safety problems intrinsic to drugs administered over long periods of 
time would have a major translational impact in cancer prevention and patient 
survivorship (Ford et al., 2009; Lien, 2009).  In view of this need, our long-term goal is 
to better understand the molecular mechanisms modulating intestinal epithelial cell 
responses to MTDB’s.  Therefore, our overall goal is to define the role of n-3 PUFA in 
the suppression of oncogenic KRas-driven colon cancer.  Initially, we focused on 
elucidating the mechanisms underlying the ability of MTDB’s to modulate plasma 
membrane architecture. (Aim 1). Secondly, we elucidated the mechanisms underlying 
the ability of MTDB’s to modulate Ras signaling through disruption of nanocluster 
complexes (Aim 2). Lastly, (Aim 3) we characterized the suppressive effects of n-3 
PUFA on macropinocytosis, a recently identified oncogenic KRas driven dependency 
(Commisso et al., 2013), in the colon.  This is both appropriate and timely, because the 
NCI has identified the “Ras Challenge” as a major initiative (Stephen et al., 2014).  In 
terms of future application, since oncogenic KRas signaling is the primary driver in the 
progression of pancreatic ductal adenocarcinoma (PDAC) (Bryant et al., 2014), select 
MTDB’s may also reduce cancer development and delay progression at multiple sites 
(Mohammed et al., 2012; Strouch et al., 2011). 
We propose a mechanistic hypothesis to generally explain the function of n-3 
PUFA bioactives.  We propose that n-3 PUFA fall into a unique class of plasma 
membrane-targeted dietary bioactives (MTDB’s) which, because of their unique 
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amphiphilic properties, are capable of modulating plasma membrane hierarchical 
organization.  By characterizing the effects of MTDB’s on plasma membrane 
protein/protein interactions, this dissertation addresses the utility of MTDB’s as a novel 
class of innocuous dietary bioactives for membrane targeted colon cancer prevention and 
therapy.   
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 CHAPTER II  
LONG CHAIN n-3 FATTY ACIDS MODIFY PLASMA MEMBRANE 
BIOPHYSCIAL PROPERTIES 
 
2.1 Introduction 
Long chain docosahexaenoic acid (DHA, 22:6Δ4,7,10,13,16,19) and eicosapentaenoic 
acid (EPA, 20:5Δ5,8,11,14,17), found in cold water fish, are generally thought to be 
beneficial for human health. Dietary intake of these compounds results in physical 
incorporation of these fatty acids into cellular plasma membrane phospholipids. The 
plasma membrane (PM) is a dynamic cellular structure composed of a myriad of lipids 
and proteins (Barrera et al., 2013).  These membrane components are exquisitely 
organized, through various forms of interactions (Garcia-Parajo et al., 2014; Nussinov et 
al., 2014).  The nomenclature used to describe these interactions varies (Sevcsik and 
Schütz, 2015), however, what is known is that perturbations to this organization can lead 
to disruption of cellular events (Kim et al., 2008; Zhou et al., 2013). Long chain PUFAs 
impart unique biophysical properties to the phospholipids they form (Shaikh et al., 2004, 
2009), which results in alterations to the spatiotemporal organization of the plasma 
membrane (Kim et al., 2008, 2014; Levental et al., 2016; Lin et al., 2016). In this study, 
we examined the mechanism and consequences of n-3 PUFA phospholipid incorporation 
on the biophysical properties of colonocyte plasma membranes. Using the membrane 
order sensitive probe Di-4-ANEPPDHQ, we demonstrate that in live cells, n-3 PUFA 
reduced the rigidity of the plasma membrane.  However, in cytoskeletal-free isolated 
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giant plasma membrane vesicles (GPMVs), we observed an increase in the rigidity of the 
membrane. This suggests that n-3 PUFA indirectly alters plasma membrane-cytoskeletal 
interactions. 
 
2.2 Results 
2.2.1 Long chain n-3 PUFA reduce murine colonocyte membrane rigidity 
To explore the effects of n-3 PUFA on plasma membrane rigidity, we utilized 
immortalized young adult mouse colonocyte (YAMC) cells (Whitehead and Robinson, 
2009), since this model faithfully recapitulates n-3 PUFA in vivo effects (Ma et al., 
2004b; Turk et al., 2012, 2013) and allows for lipidomic and proteomic studies under 
well-controlled conditions (Seo et al., 2006).  Cells were treated with a physiologically 
relevant level (50 µM) (Conquer and Holub, 1998) of albumin-complexed n-3 PUFA 
(DHA, EPA) or control long-chain n-6 PUFA linoleic acid (LA) for 72 h.  BSA-
complexed fatty acids are used to represent the non-esterified fatty acids that are bound 
to albumin in vivo.  We subsequently determined plasma membrane rigidity by 
fluorescence imaging of the membrane order sensitive probe Di-4-ANEPPDHQ (Di4) 
(Owen et al., 2012a). This probe has an advantage over another commonly used probe, 
laurdan, as it is minimally internalized in live cells (Sezgin et al., 2014). Di4 excites at 
488 nm and shifts its emission spectrum from 565 nm to 605 nm in ordered and 
disordered membranes, respectively (Owen et al., 2012a; Sezgin et al., 2014).  This shift 
in emission profile between the ordered and disordered domains allows for a quantitative 
assessment of membrane order by calculating a ratio of the fluorescent intensity in each 
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channel, known as a generalized polarization (GP) value (Figure 2.1A-D).  We validated 
our methodology by decreasing plasma membrane cholesterol levels with methyl-β-
cyclodextrins (MβCD) (Zidovetzki and Levitan, 2007), which resulted in decreased GP 
values determined by microscopy (Figure 2.1A-F) and fluorescence spectroscopy 
(Figure 2.1G & H).  
We also utilized the fat-1 transgenic mouse model which produces n-3 PUFA 
endogenously through elongation of n-6 fatty acids (Hudert et al., 2006; Kang; Kang et 
al., 2004). We have previously shown that the mole% of EPA and DHA in the colonic 
Figure 2.1. Determining membrane organization using Di-4-ANEPPDHQ.  
Membrane rigidity was determined by fluorescence microscopy or fluorescence 
spectroscopy.  Methyl-β-cyclodextrins (MβCD) reduced membrane rigidity in a dose 
dependent manner. YAMC cells were incubated with Di-4-ANEPPDHQ (2.5 uM) 
and immediately imaged to prevent internalization. Dye was excited at 488 nm and 
emission was collected from (A) 508-544 nm and (B) 651-695. These two images 
were used to generate a (C) GP image as described in methods and materials. YAMC 
cells were treated with indicated doses of MBCD for 30 minutes. (E) Histogram and 
(F) mean GP values derived from (C) control or (D) MBCD (10 uM) treated YAMC 
cells. (G) Fluorescence spectrum and (H) mean GP from YAMC cells pre-incubated 
with indicated dose of MBCD for 30 min determined by fluorescence spectroscopy.    
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mucosa of fat-1 mice is 2.13% and 2.28%, respectively, vs a control mouse with 
undetectable levels of EPA and 0.81% DHA (Jia et al., 2008).  We sought to determine 
how this incorporation would affect the rigidity of the plasma membrane in vivo. 
Overall, the plasma membrane of isolated colonic crypts from fat-1 mice was less rigid 
than control mice (Figure 2.2A&B). We further validated this observation by 
fluorescence lifetime imaging (FLIM) of Di4 (Owen et al., 2006), in which a lower 
lifetime value reflects a more fluid membrane (Figure 2.3). Exogenous supplementation 
of immortalized YAMC cells (Whitehead and Robinson, 2009) with a physiologically 
relevant (Conquer and Holub, 1998; Seo et al., 2006) dose of 50 µM bovine serum 
albumin (BSA) complexed fatty acids corroborated our in vivo findings (Figure 
2.2C&D). The n-6 polyunsaturated fatty acid linoleic acid (LA) was used as an 
additional control for assessing the general effects of fatty acid polyunsaturation. 
Figure 2.2. Long chain n-3 PUFA reduces plasma membrane rigidity in live cells. 
Isolated primary crypts or YAMC cells were incubated with 2.5 uM Di-4-
ANEPPDHQ and imaged with a confocal microscope. Representative general 
polarization (GP) images of live (A) isolated primary crypts and (C) YAMC cells. 
Mean and SEM of (B) primary crypt, (D) YAMC cells.  All values are expressed as 
delta GP (sample – control). Data represent mean +/- SEM for (B) ~30 crypts from 4 
mice per genotype, and (D) at least 10 field of views containing at least 100 cells 
from 2 independent experiments. Statistical significance between treatments as 
indicated by different letters (P<0.05) was examined using one-way ANOVA and 
uncorrected Fisher’s LSD tests.  
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Since the actin cytoskeleton plays a role in stabilizing certain membrane domains 
(Delos Santos et al., 2015; Dinic et al., 2013; Plowman et al., 2005), we sought to 
determine the effect of n-3 PUFA in a cytoskeletal free model. For this purpose, we used 
giant plasma membrane vesicles (GPMVs) which maintain much of the lipid and protein 
Figure 2.3. Plasma membrane rigidity of isolated crypts determined by FLIM. 
Isolated primary crypts, were incubated with 2.5 uM Di-4-ANEPPDHQ and average 
lifetime (ns) was determined by FLIM as described in the materials and methods. 
Representative lifetime images of live (A) wild type or (B) Fat-1 isolated primary 
crypts.  (C) Mean ± SEM of primary crypt lifetime. Data represents mean ± SEM 
from Wild type=7 and Fat-1=8 crypts from 1 animal per genotype.     
 
 
Figure 2.4. Isolated GPMVs are devoid of filamentous actin. GPMVs were generated 
from YAMC cells as described in the materials and methods. (A) Representative 
actively blebbing GPMVs from YAMC cells. (B) Membrane stained with deep red 
plasma membrane stain; (C) filamentous actin visualized by LifeAct-mCherry.  (D) 
Line scans of normalized intensity profile of GPMVs derived from (A) plasma 
membrane (PM) or (B) f-actin. 
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diversity and content of the cells from which they are derived (Sezgin et al., 2012). As 
expected, GPMVs derived from YAMC cells exhibited no structured filamentous actin 
(Figure 2.4).  
Interestingly, long chain n-3 PUFA increased the rigidity of GPMVs in vivo and 
in vitro (Figure 2.5). The opposite effects on membrane rigidity in live cells vs. GPMVs 
indirectly implicate an effect of n-3 PUFA on the actin cytoskeleton.  Interestingly, the 
effect of EPA on the rigidification of the GPMV membranes was larger than DHA, 
while LA had only a modest effect.  Further work will be necessary to elucidate the 
precise mechanism underlying n-3 PUFA’s ability to modulate cytoskeletal mediated 
plasma membrane rigidity.   
 
Figure 2.5. Long chain n-3 PUFA increase GPMV rigidity. GPMVs from isolated 
primary crypts and YAMC cells were incubated with 2.5 uM Di-4-ANEPPDHQ and 
imaged with a confocal microscope. Representative general polarization (GP) images 
of GPMVs from (A) isolated primary crypts, or (C) YAMC cells.  Mean ± SEM of 
GPMVs derived from (B) crypts or (D) YAMC cells.  All values are expressed as 
delta GP (sample – control). Data represent mean ± SEM for (B) ~150 GPMVs from 
3 mice per genotype, and (D) at least 10 field of views containing at least 100 
GPMVs from 2 independent experiments. Statistical significance between treatments 
as indicated by different letters (P<0.05) was examined using one-way ANOVA and 
uncorrected Fisher’s LSD tests.  
 
 24 
 
2.4.1 Long chain n-33 PUFA reduce human T-cell membrane rigidity ex vivo 
We next sought to determine if a different cell type would show similar effects to 
plasma membrane rigidity in comparison to colonocytes. For this we utilized CD4+ T 
cells.  
Following a 5 d incubation period, albumin bound linoleic acid (LA, C18:2n6), 
EPA and DHA were dose-dependently incorporated into human CD4+ T cell membrane 
phospholipids, as shown in Table 2.1.  Compared to the control untreated (UT) group, 
exogenous LA (n-6 PUFA control) significantly (p < 0.05) elevated membrane bound 
LA levels from 1.8 mole % to 8.1-22.7 mole%, while exogenous EPA and DHA 
Table 2.1.  Incorporation of exogenous fatty acids into activated CD4+ T cell 
membrane phospholipids. 
1Values represent mean ± SE (n = 3-7). 
2Superscript with different letters are significantly difference (P < 0.05). 
3Only selected fatty acids (> 1 mol%) are reported. 
4Abbreviations: nd, not detectable; UT, no exogenous FA treated; L12.5, LA [12.5 
µM]; L25, LA [25 µM]; L50, LA [50 µM]; E12.5, EPA [12.5 µM]; E25, EPA [25 
µM]; E50, EPA [50 µM]; D12.5, DHA [12.5 µM]; D25, DHA [25 µM]; D50, DHA 
[50 µM]. 
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significantly (p < 0.05) elevated membrane n-3 PUFA from an undetectable level to 2.8 
– 10.1 mole% for EPA, and 6.9 -12.7 mole% for DHA.  In addition, upon incorporation 
into the membrane, exogenous EPA was further elongated to docosapentaenoic acid 
(DPA, C22:5n3).  Interestingly, exogenous LA did not alter arachidonic acid (AA, 
20:4n6) levels, while only the highest dose of exogenous n-3 PUFA produced a 
compensatory reduction in AA.  Overall, the combined phospholipid levels of EPA and 
DPA (6.4 – 17.6 mol%) were comparable to DHA levels.  In addition, incubation with 
high doses of exogenous PUFA (25 and 50 µM) resulted in the incorporation of EPA, 
DPA and DHA into neutral lipid fractions as shown in Table 2.2.  
Table 2.2.  Incorporation of exogenous fatty acids into activated CD4+ T cell neutral 
lipids. 
1Values represent mean ± SE (n = 3-7). 
2Superscript with different letters are significantly difference (P < 0.05). 
3Only selected fatty acids (> 1 mol%) are reported. 
4Abbreviations: nd, not detectable; UT, no exogenous FA treated; L12.5, LA [12.5 
µM]; L25, LA [25 µM]; L50, LA [50 µM]; E12.5, EPA [12.5 µM]; E25, EPA [25 
µM]; E50, EPA [50 µM]; D12.5, DHA [12.5 µM]; D25, DHA [25 µM]; D50, DHA 
[50 µM]. 
 26 
 
 
Figure 2.6.  Exogenous fatty acids dose-dependently alter human CD4+ T cell membrane order and 
GPMV phase separation.  Human pan CD4+ T cells isolated from buffy-coat leukocytes were 
incubated with various doses (0 – 50 µM) of LA, EPA and DHA conjugated with BSA for 2 days.  
Cultures were further stimulated for 3 days with Dynabeads Human T-Activator CD3/CD28 at a bead-
to-cell ratio of 1:1, in the presence of their respective FA.  Membrane order was measured following 5 
days of total incubation. Data are expressed as the change in generalized polarization (delta GP) 
compared to the untreated (UT) group in (A) whole cells and (B) GPMVs. (C) n-3 PUFA significantly 
increased the amount of GPMVs that show phase separation. Phase separation was scored as present 
or absent. (D) Representative field of view GP images of GPMV’s (red arrows) blebbing from cells 
(white arrows), with a zoomed image clearly showing non vs phase separated GPMVs and their 
corresponding pixel distribution.  Note that GPMV’s rarely detach fully from cells. Scale bar equal 20 
µm. Data are reported as mean ± SE (n = 50-183), pooled from 3 separate experiments.   Mean values 
not sharing a common letter are significantly different (P < 0.05). 
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Following a 5 d fatty acid incubation period in the presence of CD3/CD28 ab 
stimulation (for 3 d), all 3 PUFA treatments resulted in a decrease in whole cell 
membrane order, relative to UT cells.  However, n-3 PUFA (EPA and DHA) exhibited 
significantly (p < 0.05) lower GP values compared to n-6 PUFA (LA) at the highest dose 
(50 µM) only (Figure 2.6A).  In order to determine if PUFA can directly modulate 
plasma membrane biophysical properties without the contribution of a cytoskeleton, T 
cells were incubated with a membrane order sensitive dye Di-4-ANEPPDHQ for 30 min 
prior to generation of GPMVs.  Interestingly, n-3 PUFA treated cells exhibited a 
significant (p < 0.05) elevation in membrane order compared to n-6 PUFA (LA) at 25 
and 50 µM doses (Figure 2.6B).  The striking inversion in EPA and DHA-induced 
membrane order was associated with a phase separation of the GPMV bilayer (Figure 
2.6C).  Representative images and histograms (Figure 2.6D) highlight how phase 
separation was uniquely imposed by n-3 PUFA in disordered domains that are more 
disordered, and ordered domains that are more ordered.  This is apparent in the 
histogram generated from the pixels of the LA treated GPMVs display a Gaussian 
distribution centered around -0.2, while the EPA treated GPMVs display a two Gaussian 
distribution with the most fluid centered around -0.4 and the most ridged centered 
around 0.4 (Figure 2.6D).  Interestingly, GPMV phase separation was only associated 
with the membrane level of n-3 PUFA, not the ratio of n-3/n-6 PUFA, as shown in 
Table 2.1.  
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2.3 Discussion 
The plasma membrane is an essential cellular structure composed of a 
phospholipid bilayer and a myriad of proteins, which constitute the outer boundary of 
the cell.  Not only does the cell membrane control molecular transport, it also regulates 
communication between the cell and its environment by transducing signals.  Recent 
studies have documented important functions for plasma membrane lipids in regulating 
cellular signaling (Turk et al., 2012).   One method that the cell utilizes to organize the 
membrane relies on cholesterol, which generates biophysical interactions that generate 
highly packed and ordered, rigid domains commonly referred to as “lipid-rafts” 
(Levental and Veatch, 2016; Sezgin et al., 2017).  From a functional perspective, the 
cholesterol / phospholipid composition of cellular membranes is known to influence 
lipid raft formation and the ability of plasma membrane receptors / signaling proteins to 
function properly (Griffié et al., 2015; Hou et al., 2016; Phillips et al., 2009).  Recently 
the biophysical properties of the plasma membrane have been linked to various cellular 
processes, such as EMT (Tisza et al., 2014), cell cycle progression (Gray et al., 2015), 
insulin secretion (Sezgin et al., 2015) and various chronic disease processes (McDonald 
et al., 2014; Miguel et al., 2011). Since some of the biophysical properties of the plasma 
membrane result from cytoskeletal driven interactions (Alvarez-Guaita et al., 2015; 
Dinic et al., 2013), we sought to compare and contrast the effect of n-3 PUFAs in both 
live cells and cytoskeletal free GPMVs.  
Interestingly, long chain n-3 PUFA reduced membrane rigidity in live cells (Fig 
2), while elevating membrane order in isolated GPMVs (Fig 3), implicating an indirect 
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effect of the cytoskeleton. This is not surprising given that fact that n-3 PUFA are known 
to suppress phosphatidylinositol 4,5-bisphosphate (PIP2)-dependent actin remodeling 
during CD4+ T-cell activation (Hou et al., 2012) and attenuate activation of the 
cytoskeletal remodeling proteins Rac1 and Cdc42 (Turk et al., 2013) in colonocytes.  In 
addition, similar effects of DHA on phase separation stability in GPMVs derived from 
rat basophilic leukemia (RBL) cells have been reported (Levental et al., 2016).  
With respect to T-cells, fatty acid composition has been linked to immune (Hou 
et al., 2012, 2015; Kim et al., 2008; Yog et al., 2010) and inflammatory homeostatic 
responses (Calder, 2015; Monk et al., 2014). Therefore, we isolated highly purified, 
viable, primary human CD4+ T cells (> 96% viability) from buffy-coat leukocytes and 
demonstrated the dose-dependent in vitro incorporation and elongation of exogenous 
PUFA into cell membrane phospholipids (Table 2.1).  We observed that exogenous EPA 
was extensively elongated to DPA (22:5n-3), a process that is common to other cell 
types (Chapkin and Carmichael, 1990; Chapkin et al., 1991).   
Since changes in membrane lipid order have been associated with immune cell 
function and inflammatory disease status (McDonald et al., 2014; Miguel et al., 2011), it 
is noteworthy that EPA or DHA differentially dose-dependently modulated membrane 
lipid order in whole CD4+ T cells vs GPMVs as compared to UT or n-6 PUFA control 
treatments (Figures 2.6A&B).  Interestingly, at higher doses of n-3 PUFA in vitro, a 
profound induction of phase transition was induced which contributed to an increase in 
GPMV membrane rigidity (Figure 2.6).   
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Recently, GPMVs have attracted great attention in studies focusing on cell 
membrane biophysical properties, due to the fact that they are comprised of the 
membrane bilayer without the contribution of the cytoskeleton (Sezgin et al., 2012). 
Thus, by contrasting in vitro effects of n-3 PUFA on membrane order in live cells vs 
GPMV, our findings suggest the involvement of the cytoskeleton in the modulation of 
membrane lipid order.  The striking membrane phase separation in CD4+ T cell derived 
GPMVs is consistent with previous studies examining polyunsaturated lipids (Levental 
et al., 2016), cholesterol (Levental et al., 2009), bile acids (Zhou et al., 2013), anesthetics 
(Gray et al., 2013; Machta et al., 2016), chemotherapeutics (Raghunathan et al., 2015), 
cell cycle progression (Gray et al., 2015), epithelial-mesenchymal transition (Tisza et al., 
2014), and protein lipid interaction (Podkalicka et al., 2015).  The ability of n-3 PUFA to 
induce phase separation at room temperature in GPMVs has been linked to suppression 
of Snail function and the inhibition of lung metastasis (Tisza et al., 2014).  Therefore, the 
unique phase separation in human CD4+ T cell GPMVs by high dose n-3 PUFA may be 
a biomarker for predicting the potential of n-3 PUFA to suppress chronic disease 
progression. 
In conclusion, we have demonstrated that n-3 PUFA in vitro and in vivo increase 
mouse colonocyte and human CD4+ T cell membrane fluidity by reducing lipid order 
and promote phase separation in GPMVs.  
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2.4 Materials and methods 
2.4.1 Materials 
RPMI 1640 medium, Leibovitz medium, FBS, Glutamax, penicillin, 
streptomycin and Dynabeads Human T-Activator CD3/CD28 were purchased from 
Gibco (Gaithersburg, MD).  Leucosep tubes were obtained from Greiner Bio One 
(Monroe, NC).  Ficoll-Paque medium was purchased from GE (Pittsburgh, PA).  RBC 
lysis buffer was obtained from BioLegend (San Diego, CA).  EasySep human CD4+ T 
cell isolation kits were purchased from StemCell technologies (Cambridge, MA).  Poly-
L-lysine was purchased from Sigma (St. Louis, MO).  Di-4-ANEPPDHQ was obtained 
from Invitrogen (Carlsbad, CA).  Glass bottom 35-mm dishes were purchased from 
MatTek Corporation (Ashland, MA).  CellTiter-Blue cell viability assay was obtained 
from Promega (Madison, WI).  Silica gel 60 G plates and all organic solvents were 
purchased from EM Science (Gibbstown, NJ).  Free fatty acids and fatty acid methyl 
ester standards were purchased from NuChek Prep (Elysian, MN).  
 
2.4.2 YAMC Cell Culture 
  Conditionally immortalized Young Adult Mouse Colonic (YAMC) cells and 
YAMC-HRasG12V were originally obtained from R.H. Whitehead, Ludwig Cancer 
Institute (Melbourne, Australia).  YAMC cells (passages 14–19) were cultured under 
permissive conditions, 33°C and 5% CO2 in RPMI 1640 media (Mediatech, Manassas, 
VA) supplemented with 5% fetal bovine serum (FBS; Hyclone, Logan, UT), 2 mM 
GlutaMax (Gibco, Grand Island, NY), 5 μg/mL insulin, 5 μg/ml transferrin, 5 ng/ml 
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selenious acid (Collaborative Bio-medical Products, Bedford, MA), and 5 IU/mL of 
murine interferon-γ (Roche, Mannheim, Germany). Isogenic SW48 parental and 
KRasG12D cells (Horizon Discovery) were maintained at 33°C and 5% CO2 in McCoy’s 
5A medium supplemented with 10% FBS.  Select cultures were treated for 72 h with 50 
μM fatty acid [linoleic acid (LA, 18:2n6), arachidonic acid (AA, 20:4n6), 
eicosapentaenoic acid (EPA, 20:5n3) or docosahexaenoic acid (DHA, 22:6n3); NuChek, 
Elysian, MN] complexed with fatty acid free bovine serum albumin (BSA). 
 
2.4.3 CD4+ T cell isolation and culture 
  Buffy-coat leukocyte source from Gulf Coast Regional Blood Center (Houston, 
TX) or freshly collected whole blood was layered onto Leucosep tube containing Ficoll-
Paque medium followed by 800 x g centrifugation for 15 min.  Peripheral blood 
mononuclear cells (PBMC) were collected from the interphase and washed once with PBS 
(Rees et al., 2006).  Red blood cell (RBC) contamination was removed by incubating cell 
pellets in 1X RBC Lysis buffer on ice for 5 min, followed by PBS washing. CD4+ T cells 
from PBMC were purified by negative selection using an EasySep human CD4+ T cell 
isolation kit following the manufacture’s protocol.  The purity of viable CD4+ T cell 
population as analyzed by flow cytometry was 96.5 ± 1.2 % (n=3). 
  CD4+ T cells isolated from the buffy-coat leukocyte source were incubated with 
various doses (0 – 50 µM) of linoleic acid (LA, 18:2n6), eicosapentaenoic acid (EPA, 
20:5n3) or DHA conjugated with BSA for 2 days (basal state).  Basal T cell bioenergetic 
profiles were measured at the end of the first 2 days of incubation.  In addition, select 
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cultures were stimulated for an additional 3 day period with Dynabeads Human T-
Activator CD3/CD28 at a bead-to-cell ratio of 1:1 in the presence of exogenous FA (0 – 
50 µM LA, EPA or DHA) (activated state).  FA incorporation, membrane order, cell 
proliferation and bioenergetic profiles were subsequently determined. 
 
2.4.4 GPMV generation and membrane order measurement 
  Giant plasma membrane vesicle (GPMV) generation was performed as described 
previously (Sezgin et al., 2012).  Briefly, basal or activated CD4+ T cells were pelleted 
and re-suspended in GPMV vesiculation buffer (10 mM HEPES, 150 mM NaCl, 2 mM 
CaCl2, pH 7.4, 25 mM PFA, 2 mM dithiothreitol) for at least 1 h at 37°C.  GPMVs were 
then spun down at 2000 x g for 3.5 min and pellets were re-suspended in serum-free 
Leibovitz medium containing Di-4-ANEPPDHQ (5 μM), transferred to a 35-mm glass 
bottom dish, and immediately imaged. For Adherent YAMC cells GPMVs were generated 
similarly, however, attachment of cells allowed collection of GPMV enriched supernatant 
without the need for centrifugation. GPMV rich supernatant was then used for imaging.  
 
2.4.5 Membrane order imaging and quantification 
  Basal or activated whole CD4+ T cells were stained with Di-4-ANEPPDHQ for 
membrane order determination as previously described (Owen et al., 2011; Chapkin et al., 
2014). Briefly, T-cells were gently pelleted at 200 x g for 5 min, re-suspended in serum-
free Leibovitz medium containing Di-4-ANEPPDHQ (5 μM), transferred to a 35-mm 
glass bottom dish, and immediately imaged to avoid dye internalization. YAMC cells were 
 34 
 
washed with Leibowitz, followed by incubation in serum-free Leibovitz medium 
containing Di-4-ANEPPDHQ (5 μM), and immediately imaged to avoid dye 
internalization. 
  Imaging experiments were conducted on a Zeiss 510 or a Zeiss 780 confocal 
microscope equipped with a 32-channel GaAsP line-array spectral detector.  YAMC cells 
and crypts were imaged with a 1.4 numerical aperture 40× Plan Apochromat oil objective, 
while T-cells and GPMVs were imaged with a 1.4 numerical aperture 63× Plan 
Apochromat oil objective at room temperature.  Laser light at 488 nm was used to excite 
Di-4-ANEPPDHQ and emission wavelengths were collected in two channels representing 
order (O: 508-544) and disordered (D: 651-695).   
  Generalized polarization (GP) was calculated using the equation below: 
GP= (I(O)-I(D))/(I(O)+I(D)).  The same laser power and settings were used for every 
experiment.  Image processing was conducted using Fiji/ImageJ (NIH) software, with a 
GP-plugin and a custom-built macro.  Briefly, images were converted to 8-bit tiffs, 
combined into RBG images, thresholded to exclude background pixels, and converted into 
GP images.  Average GP was determined from region of interest (ROI) of cells or GPMVs. 
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 CHAPTER III  
LONG CHAIN n-3 FATTY ACIDS ATTENUATE ONCOGENIC RAS DRIVEN 
PROLIFERATION BY ALTERING PLASMA MEMBRANE PROTEIN 
NANOCLUSTERING 
3.1 Introduction 
Ras GTPase proteins are targeted to the cytoplasmic face of the plasma 
membrane by farnesylation coupled to either palmitoylation, N, H and K(A) or a 
polybasic motif, K(B) (Eisenberg et al., 2013).  Approximately 30-50% of colorectal 
cancers (CRCs) harbor KRas mutations, and KRas-mutant CRCs exhibit resistance to 
standard therapy (Stephen et al., 2014), thereby reducing survival (Phipps et al., 2013).  
Moreover, to date, targeting of mutant RAS proteins in cancers has not been possible 
(Phipps et al., 2013).  A number of Ras effector proteins and cell signaling pathways 
have been defined, including the Raf and the MAP kinase pathway, the PI3K and the 
Akt/mTOR pathway, and the RalGDS and Ral pathway.  RAS effector proteins 
physically associate with RAS proteins to propagate signal transduction (Herrmann, 
2003; Wittinghofer and Herrmann, 1995). These effectors are highly complex with 
numerous redundancies and interactions between pathways (Downward, 2003). 
Dysregulated (oncogenic) Ras signaling results in increased proliferation, decreased 
apoptosis, disrupted cellular metabolism, and increased angiogenesis, all seminal 
hallmarks of cancer (Downward, 2003; Vasan et al., 2014).  Thus, there is a critical need 
to develop new KRas targeted therapeutic approaches with reduced toxicities in the 
setting of acute or chronic administration. 
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High fidelity signaling of K-Ras is dependent on its spatial organization into 
defined dimers (Muratcioglu et al., 2015; Nan et al., 2015) or nanoclusters containing 
~6-7 Ras molecules, measuring ~9 nm in radius in the inner leaflet of the plasma 
membrane (Henis et al., 2009; Tian et al., 2007).  Recently, it was demonstrated that 
select amphiphilic agents, through direct modulation of the biophysical properties of the 
plasma membrane, compromise oncogenic K-Ras nanoclustering to modulate signal 
transduction (Zhou and Hancock, 2015; Zhou et al., 2012).  These findings suggest that 
Ras nanoclusters could be a novel therapeutic target (Cho and Hancock, 2013; Zhou et 
al., 2010).  From this perspective, there is a growing body of evidence indicating that n-3 
PUFA, found in cold water fish and over the counter supplements and prescription 
therapeutics, e.g., Lovaza, can attenuate oncogenic Ras signaling (Collett et al., 2001; 
Ma et al., 2004b; Rogers et al., 2010; Seo et al., 2006; Turk et al., 2012).   
With respect to the molecular mechanism of action, there is a growing body of in 
vitro and in vivo evidence indicating that n-3 PUFA reshape plasma membrane domains. 
For example, EPA and DHA, whose membrane phospholipid levels are readily 
influenced by diet in general (Katan et al., 1997), are rapidly incorporated into cells, 
primarily into membrane phospholipids at the sn-2 position (Chapkin et al., 1991; 
Williams et al., 2012). The presence of long chain n-3 PUFA in membrane 
phospholipids imparts unique biophysical properties which have been linked to 
alterations in plasma membrane structure and function (Chapkin et al., 2008b; Levental 
et al., 2016; Ma et al., 2004a, 2004b; Seo et al., 2006; Williams et al., 2012).  For 
example, DHA is known to influence membrane fluidity, ion permeability, fatty acid 
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exchange, and resident protein function (Hou et al., 2016; Stillwell and Wassall, 2003), 
including the inhibition of epidermal growth factor receptor (EGFR)  signaling in tumor 
bearing mice by disassociating EGFR from lipid rafts (Turk et al., 2012).  Since changes 
in the biophysical properties of the plasma membrane have been linked to alterations in 
Ras signal transmission (Zhou and Hancock, 2015; Zhou et al., 2012), we hypothesized 
that select amphiphilic membrane targeted dietary bioactives (MTDBs) modulate Ras 
nanocluster formation.  Herein, we report DHA and EPA (i) modify Ras nanocluster 
formation, (ii) disrupt oncogenic Ras driven signaling (pERK), and (iii) suppress 
phenotype (hyperproliferation) in vitro and in vivo.  Together, these results suggest a 
unique role for MTDBs in the modulation of Ras nanoscale spatial organization and 
signaling. 
 
3.2 Results 
3.2.1 Dietary n-3 PUFA ameliorate oncogenic KRasG12D mediated colonic 
phenotypes in vivo.  
We previously demonstrated that n-3 PUFA suppress intestinal wild type H- 
and KRas activation in vitro and in vivo, leading to a reduction in downstream 
signaling (Ma et al., 2004b; Turk et al., 2012). Interestingly, the effects of n-3 PUFA 
are not limited to wild type Ras, as DHA also attenuates activation of ERK and 
reduces the growth of mouse colonocytes expressing oncogenic HRas (Collett et al., 
2001; Turk et al., 2012).  This is consistent with studies documenting the ability of n-3 
PUFA to reduce cell proliferation, signaling, and anchorage independent growth in 
 38 
 
colon cancer cell lines (HCT116, SW480, SW620) and pancreatic ductal 
adenocarcinoma models harboring KRas mutations G12V and G13D (Dunn et al., 
2011; Fasano et al., 2012; Liu et al., 2016; Mohammed et al., 2012; Rogers et al., 
2010; Schonberg et al., 2006; Strouch et al., 2011).  To determine if dietary n-3 PUFA 
can suppress oncogenic Ras mediated phenotypes, we utilized an inducible genetic 
model of oncogenic KRas driven colonic hyperproliferation. (Feng et al., 2011, 
Figure 3.1.  Dietary n-3 PUFA ameliorates oncogenic KRasG12D mediated colonic 
phenotypes. (A) Experimental design to determine the efficacy of dietary intervention 
on a (B) genetic mouse model of oncogenic KRasG12D driven hyper-proliferation in 
the colon, (C) alcian blue-staining of colonic crypts, (D) Nuclei (blue) and edu-
labeled (red) proliferating colonocytes in mice 4 weeks post tamoxifen (Tam, 200 
mg/kg) fed corn or fish oil-containing diets. Quantitative analysis of (E) crypt length 
and (F) cell proliferation. Scale bar = 50 µM. Statistical significance between 
treatments as indicated by different letters (P<0.05) was examined using one-way 
ANOVA and uncorrected Fisher’s LSD tests (Panel E; n = 4 mice per group and at 
least 508 crypts counted; Panel F; n = 4 mice per group and 200 crypts counted). 
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2013)(Figures 3.1A & B).  Mice were fed a diet containing corn (n-6 PUFA control) 
or fish oil (Tables 3.1 & 3.2) for 2 wks prior to tamoxifen induction of oncogenic 
KRas, and maintained for an additional 4 weeks (Figure 3.1A).  This dose is 
comparable to a diet containing approximately 8.6 g/day n-3 PUFA in humans 
(Fuentes et al., 2017).  As expected, mice fed a diet containing n-3 PUFA exhibited an 
enrichment of DHA and EPA in membrane phospholipids (Table 3.3).  Dietary n-3 
PUFA treatment substantially reduced colonic hyperproliferation as indicated by the 
significant (P<0.05) reduction of crypt length (Figures 3.1C & E) and number of Edu 
positive proliferative cells per crypt (Figures 3.1D & F). Collectively, these findings 
suggest that dietary fish oil containing EPA and DHA can attenuate oncogenic KRas 
driven phenotypes in vivo.  
Table 3.1.  Mouse diet composition. 
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Table 3.2.  Mouse diet fatty acid composition. 
1Values represent means from lipids extracted from ~ 1g of experimental diet.  
2Only selected fatty acids in which at least one observation was > 0.2 mol% are 
reported. 
 
Table 3.3.  Incorporation of exogenous fatty acids into murine colonic crypt 
membrane phospholipids.  
1Values represent mean ± SEM (n = 4 mice per treatment). 
2Statistical significance between treatments as indicated by different letters (P<0.05) 
was examined using one-way ANOVA and uncorrected Fisher’s LSD tests.  
3Only selected fatty acids in which at least one observation was > 0.2 mol% are 
reported. 
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3.2.2 Long chain n-3 PUFA disrupt Ras spatiotemporal dynamics.   
   Previous experiments conducted by our lab using immuno-gold electron 
microscopy of plasma membrane sheets, suggest that plasma membrane organization of 
inner leaflets is fundamentally altered by EPA and DHA (Chapkin et al., 2008b; Kim et 
al., 2010).  Specifically, n-3 PUFA treatment altered the nanoclustering of truncated 
forms of wild type H- and KRas in cervical adenocarcinoma (HeLa) and colorectal 
carcinoma (HCT-116) cells (Chapkin et al., 2008b; Kim et al., 2010).   Nanoclustering 
of Ras isoforms is primarily controlled by distinct C-terminal hypervariable regions 
(HVR) which share ~20% homology among Ras protein species (Prior and Hancock, 
2001, 2012). As a tool to study Ras nanoclustering, fluorescent GFP and RFP proteins 
are attached to the minimal membrane anchoring domain of H- or K-Ras (Prior et al., 
2003). When the technique of fluorescence lifetime imaging microscopy combined with 
fluorescence resonance energy transfer (FLIM-FRET) is applied to cells transiently 
expressing these probes it allows for the quantification of the nanoscale organization of 
these proteins (Najumudeen et al., 2016; Zhou and Hancock, 2017; Zhou et al., 2012, 
2015).  Importantly, transient expression of these probes faithfully reports on the 
nanoscale interactions of Ras, as the clustered fraction of Ras proteins remains constant 
over a multi-log range of expression levels (Plowman et al., 2005; Tian et al., 2007; 
Zhou and Hancock, 2015).  A reduction of GFP lifetime is indicative of more extensive 
FRET as a result of a smaller distance between GFP and RFP, which is correlated with 
more extensive nanoclustering.  Lifetime values are then converted to apparent FRET 
efficiency %, where an increase is indicative of enhanced nanoclustering (Guzman et 
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al., 2014).  To further explore the effects of n-3 PUFA on Ras spatiotemporal dynamics, 
we utilized immortalized young adult mouse colonocyte (YAMC) cells (Whitehead and 
Robinson, 2009), since this model faithfully recapitulates n-3 PUFA in vivo effects (Ma 
et al., 2004b; Turk et al., 2012, 2013) and allows for lipidomic and proteomic studies 
under well-controlled conditions (Seo et al., 2006).  Cells were treated with a 
physiologically relevant level (50 uM) (Conquer and Holub, 1998) of albumin-
complexed n-3 PUFA (DHA, EPA) or control long-chain n-6 PUFA linoleic acid (LA) 
for 72 h.  In addition, mevastatin, an HMG-CoA inhibitor was used as a positive control 
Figure 3.2.  Long chain n-3 PUFA disrupts Ras spatiotemporal dynamics.  
Nanoclustering-FRET analysis (illustrated in schemes) in (A) YAMC cells co-
expressing GFP- and RFP-tagged (B) truncated K-Ras (tK), (D) truncated H-Ras (tH) 
or (F) tH-GFP and tK-RFP. (A) Representative examples of FLIM-FRET images of 
YAMC cells from the different FRET samples as indicated. (C, E, G) YAMC cells 
were treated with mevastatin (Mev, 5 uM) or indicated fatty acids (50 uM) for 24 or 
72 h, respectively. Cells were transfected 48 h prior to imaging.  In all graphs (C, E 
and G), the apparent FRET efficiency was calculated from FLIM data (mean ± SEM, 
n= 2-3 and independent experiments).  Values in the bars indicate the number of cells 
examined.  Statistical significance between treatments as indicated by different letters 
(P<0.05) was examined using one-way ANOVA and uncorrected Fisher’s LSD tests.  
Un – untreated cells, LA – linoleic acid, EPA – eicosapentaenoic acid, DHA – 
docosahexaenoic acid. 
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to reduce nanoclustering of Ras and FRET efficiency by blocking farnesylation and thus 
membrane anchorage of Ras (Kohnke et al., 2012).  Surprisingly, n-3 PUFA 
significantly increased (P<0.05) the clustering of truncated KRas (tK) (Figures 3.2A - 
C) while truncated HRas (tH) (Figures 3.2D & E) clustering was reduced (P<0.05) 
compared to untreated control.  Since n-3 PUFA are known to modulate differences in 
membrane rigidity between raft and non-raft domains (Levental et al., 2016; Lin et al., 
2016), we sought to determine if this would result in the formation of mixed heterotypic 
nanoclusters of tH and tK, as observed with certain nonsteroidal anti-inflammatory drugs 
(Zhou et al., 2012).  DHA and EPA significantly increased (P<0.05) the formation of 
heterotypic clustering, as well as LA to a lesser extent (Figures 3.2F & G). 
Polyunsaturation of lipids in general, may have a minor effect on the lateral segregation 
of H- and K-Ras since, LA did increase heterotypic clustering but had no effect on 
homotypic clustering.  This suggests that incorporation of long chain n-3 PUFA into 
plasma membrane phospholipids alters the precise nanometer spatial organization of H- 
and KRas, thereby enhancing heterotypic mixed clusters.  
 
3.2.3 Long chain n-3 PUFA attenuate oncogenic Ras mediated ERK signaling. 
  We next sought to determine if the nanoscale alterations to Ras organization 
imposed by n-3 PUFA attenuate oncogenic Ras signaling defects.  We initially tested 
YAMC cells expressing oncogenic HRasG12V (D’Abaco et al., 1996) as a 
representation of normal colonocytes en route to malignancy (Smith et al., 2002).  Since 
physiological expression of oncogenic KRas does not result in large increases in 
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phosphorylation of ERK, we therefore stimulated cells with EGF (Stolze et al., 2015; 
Vartanian et al., 2013).  As detected by immunofluorescence staining of phosphorylated 
ERK, EPA and DHA reduced (P<0.05) EGF induced ERK phosphorylation by ~13 and 
29%, respectively (Figures 3.3A & B).  In contrast, the n-6 PUFA control (LA) had no 
Figure 3.3.  Long chain n-3 PUFA attenuated Ras mediated ERK signaling.  (A) 
YAMC-HRasG12V or (C) SW48-KRasG12D cells grown in 8-well glass bottom 
dishes and treated with 50 uM indicated fatty acid for 72 h.  Cells were starved (0.5% 
FBS) over the final 18 hours in the presence of fatty acid and stimulated with EGF 
(25 ng/ml) for 5 min, then immediately fixed in ice cold 100% methanol. (A, C) 
Representative masked images of cells immunostained for pERK +/- EGF.  Color 
scale represents relative fluorescence intensity.  Scale bar = 20 µM. (B and D) 
Average fluorescence intensity for pERK.  Data represent average fluorescence 
intensity ± SEM from at least 15 fields of view with ~20-30 cells per field, from 3 
independent experiments.  Statistical significance between treatments as indicated by 
different letters (P<0.05) was examined using one-way ANOVA and uncorrected 
Fisher’s LSD tests. 
 45 
 
effect compared to untreated control (Figure 3.3B).  Since oncogenic HRas is not 
commonly mutated in colon cancer (Prior et al., 2012), we subsequently utilized a human 
colon cancer SW48 cell line expressing mutated KRas (Hammond et al., 2015; Modest 
et al., 2013; Vartanian et al., 2013).  This cell line model was generated using adeno-
associated virus (AAV) somatic homologous recombination-based technology to 
directly modify endogenous Ras genes via introduction of activating mutations (Inoue 
et al., 2001; Russell et al., 2002).  To limit the confounding effects associated with over-
expression of oncogenic Ras, these cells were designed to express mutated KRas variant 
G12D from the endogenous KRas locus (Stolze et al., 2015).  This particular KRas 
variant was chosen because one third of colorectal tumors harbor KRas mutations and 
~80% of these mutations are at codon 12, while the remaining mutations are at codon 13 
(Prior et al., 2012). Consistent with treatment effects on mutant HRas, DHA and EPA 
also reduced (P<0.05) EGF stimulated ERK phosphorylation in SW48-KRasG12D cells 
relative to the n-6 PUFA (LA) and untreated controls (Figures 3.3C & D). 
 
3.2.4 Dietary n-3 PUFA disrupt Ras spatiotemporal dynamics and suppress oncogenic 
Ras-mediated hyperproliferation in Drosophila intestinal stem cells.   
  In order to assay n-3 PUFA-mediated changes of Ras nanoclustering in vivo, we 
turned to the Drosophila intestinal (midgut) epithelium. The presence of somatic intestinal 
stem cells (ISCs) within the fly midgut allows for the use of a wide range of genetic tools 
to assay signalling events that govern proliferative homeostasis in vivo (Biteau et al., 2011; 
Buchon et al., 2013; Micchelli and Perrimon, 2006; Ohlstein and Spradling, 2006).  This 
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Figure 3.4.  Dietary n-3 PUFA disrupts Ras spatiotemporal dynamics, suppresses oncogenic Ras 
driven hyperproliferation phenotype and signaling in Drosophila midguts. (A) Schematic diagram of 
drosophila intestine. (B) Representative intensity and lifetime field of view (FOV) images of 
Drosophila midguts.  Nanoclustering-FRET analysis (illustrated in schemes) in Drosophila midgut 
stem cells co-expressing GFP- and RFP-tagged (C) truncated K-Ras (tK), (D) truncated H-Ras (tH) or 
(E) tH-GFP and tK-RFP. (C, D, and E) 1-2 d old Drosophila were placed on holidic diet containing no 
lipid (red) or fish oil (purple) for 5 d prior to dissection and mounting of midguts for microscopy.  In 
all graphs (C, D and E), the apparent FRET efficiency was calculated from FLIM data (mean ± SEM, 
n=2 independent experiments).  Values in the bars indicate the number of analyzed FOVs.  Induction 
of oncogenic RasV12 in Drosophila midgut stem cells resulted in (F) hyperproliferation at 24 hours 
and luminal thickening at 48 hours.  Drosophila fed a fish oil vs control holidic diet for 5 d prior to 
induction of oncogenic RasV12 in midgut stem cells exhibited reduced hyperproliferation and midgut 
luminal thickening. (G) Quantitative analysis of proliferation as assed by pH3 at 48 hours post RasV12 
induction.  (H) After 24 hour RasV12 induction, guts were harvested and used to assess pERK by 
western blot. Statistical significance between treatments as indicated by different letters (P<0.05) was 
examined using an unpaired t-test. 
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barrier epithelia, with functional and morphological similarities to the mammalian small 
intestine and mouse airway epithelia (Biteau et al., 2011), contains ISCs that can 
asymmetrically divide, forming an enteroblast (EB) that directly differentiates into 
functional enterocytes (Figure 3.4A). Thus, the Drosophila ISC lineage provides an 
excellent model to study signaling mechanisms regulating stem cell maintenance and 
dysfunction, including EGFR/Ras-mediated proliferative signaling (Biteau et al., 2011; 
Jiang and Edgar, 2009).   
  To extend our findings in YAMC cells in vivo, we assessed n-3 PUFA-dependent 
effects on Ras nanoclustering in Drosophila utilizing transgenic flies that express Ras 
FRET pair constructs (UAS-GFP/RFP-truncated KRas and/or UAS-GFP/RFP-truncated 
Table 3.4.  Drosophila diet fatty acid composition.  
1Values represent means from lipids extracted from ~ 1g of experimental diet.  
2Only selected fatty acids in which at least one observation was > 0.2 mol% are 
reported. 
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HRas) (Zhou et al., 2015) specifically within ISCs/EBs (using the EsgGal4 driver). 
Control flies expressing only the UAS-GFP-truncated KRas/esgGal4 stem cell driver 
(lacking the FRET pair; establishes baseline lifetime of GFP with no FRET interaction) or 
UAS-GFP/RFP truncated HRas/esgGal4 (used to comparatively determine treatment 
effects on clustering of HRas) were also assessed. Flies were fed a chemically defined 
holidic diet (Piper et al., 2014) that allowed for precise control over all ingredients.  The 
experimental diet differed from the control diet only in its lipid profile – fish oil 
presented at 1.79% (w/w) (Tables 3.4).  t-BHQ was added to the diet to prevent 
oxidative deterioration of EPA/DHA (Fritsche and Johnston, 1988).  Phospholipid 
analysis of the midgut indicated that EPA, and to a lesser extent DHA, was enriched in 
Table 3.5.  Incorporation of exogenous fatty acids into Drosophila gut membrane 
phospholipids. 
1Values represent means from pooled Drosophila guts (n= Control 51, and Fish Oil 
46), grown in two separate vials.  
2Only selected fatty acids in which at least one observation was > 0.2 mol% are 
reported. 
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flies feeding on the n-3 PUFA-enriched diet (Table 3.5).  Utilizing these dietary and 
genetic conditions, we then performed FLIM-FRET to monitor truncated H- and KRas 
nanoclustering in Drosophila intestinal stem cells/enteroblasts. Consistent with our in 
vitro nanoclustering data (Figures 3.2B-G), flies on the fish oil diet had increased tK 
clustering, reduced tH clustering and increased formation of heterotypic clustering 
(Figure 3.4B-E).  In a complementary set of experiments, flies were fed an additional 
n-6 PUFA control diet containing equal amounts of lipid (corn oil) (Tables 3.4).  This 
resulted in a dramatic increase in LA-containing phospholipids (Table 3.6), however no 
effect on tK or tH clustering was observed (Figure 3.5).  Finally, we examined the effect 
of dietary n-3 PUFA on oncogenic Ras-mediated phenotypes originating from stem cells 
in the Drosophila midgut.  For this purpose, the expression of oncogenic RasV12 was 
Table 3.6.  Incorporation of exogenous fatty acids from corn oil into Drosophila gut 
membrane phospholipids. 
1Values represent means from pooled Drosophila guts (n= Corn Oil 28), grown in 
two separate vials.  
2Only selected fatty acids in which at least one observation was > 0.2 mol% are 
reported. 
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targeted to ISCs in the adult fly, which leads to stem cell hyperproliferation and intestinal 
dysplasia (Figure 3.4F) (Jiang and Edgar, 2009).  Strikingly, flies fed n-3 PUFA vs 
control exhibited a drastic reduction in stem cell hyperproliferation, luminal 
thickening/tissue dysplasia (Figures 3.4F-G) and ERK activation (Figure 3.4H).  
Collectively, these data demonstrate that dietary fish oil results in the incorporation of 
n-3 PUFA into plasma membrane phospholipids in Drosophila ISCs, which is associated 
with the disruption of Ras nanoscale organization, and the amelioration of oncogenic 
Ras-dependent signaling and hyperproliferation in vivo. 
 
3.3 Discussion 
  Here we provide evidence that a diet containing long chain n-3 PUFA, e.g., EPA 
and DHA, attenuate oncogenic Ras signaling by altering its precise nanoscale spatial 
Figure 3.5.  Dietary corn oil does not disrupt Ras spatiotemporal dynamics in 
Drosophila midguts.  Nanoclustering-FRET analysis (illustrated in schemes) in 
Drosophila midgut stem cells co-expressing GFP- and RFP-tagged (A) truncated 
KRas (tK) or (B) truncated HRas (tH).  (B and D) 1-2 d old Drosophila were placed 
on holidic diet containing no lipid (red) or corn oil (green) for 5 d prior to dissection 
and mounting of midguts for microscopy.  In all graphs (B and D), the apparent 
FRET efficiency was calculated from FLIM data (mean ± SEM, n= (B) 2 or (D) 1 
independent experiment(s)).  Values in the bars indicate the number of analyzed 
FOVs.  Statistical significance between treatments as indicated by different letters 
(P<0.05) was examined using an unpaired t-test. 
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organization.  To our knowledge, this is the first in vivo evidence that dietary bioactives 
can fundamentally alter Ras membrane organization and signaling in the intestine.  This 
is highly relevant since no curative treatments for KRas-driven colon cancer are 
available.  From a translational and feasibility perspective, these findings lay the 
foundation for the development of toxicologically innocuous KRas therapeutic 
approaches.  Our data suggest that membrane therapy as a strategy likely requires the 
long term shaping of cellular phospholipids and hence their resident proteins (Escriba et 
al., 2015).  The use of a prolonged regimen as a therapeutic strategy would ideally need 
to exhibit little or no adverse effects.  From a human dose perspective, EPA and DHA 
administration as high as 17.6 g/day has been shown to be safe and well tolerated (Skarke 
et al., 2015). This is opposed to traditional therapeutic approaches which often exhibit 
off target effects and unwanted toxicological ramifications (Muller and Milton, 2012). 
  With respect to membrane structure, the plasma membrane is composed of a 
heterogeneous mixture of lipids and proteins, whose distinct order maintains efficient 
signal transduction.  Membrane lipids typically undergo phase separations and interact 
selectively with membrane proteins and sub-membrane cytoskeletal elements (Horejsi and 
Hrdinka, 2014).  Accumulating evidence suggests that lipid rafts are highly dynamic and 
small (5-200 nm) membrane microdomains enriched in sphingolipids and/or cholesterol, 
which function as sorting platforms for many membrane-associated proteins (Frisz et al., 
2013; Hancock, 2006; Kraft, 2013; Levental and Veatch, 2016; Lingwood and Simons, 
2010).   Stabilization of these domains is generally thought to be maintained by lipid and 
cytoskeletal influences (Head et al., 2014).  This is noteworthy from a cancer perspective 
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because lipid rafts may modulate the malignant transformation process.  For example, the 
levels of lipid rafts are increased in many types of cancer (Jahn et al., 2011; Li et al., 2006; 
Patra, 2008) and the  modulation of raft properties by DHA may impact epithelial-
mesenchymal transition (EMT) (Tisza et al., 2014).  There is also evidence suggesting that 
disruption of lipid rafts in cancer can lead to increased responsiveness to anti-cancer 
therapies (Fedida-Metula et al., 2012; Irwin et al., 2011).  Additionally, some anti-cancer 
drugs have beneficial effects through alteration of the protein content of lipid rafts (George 
and Wu, 2012; Hryniewicz-Jankowska et al., 2014).  In colon cancer, lipid rafts have been 
shown to function in cell death-mediated signaling (Lacour et al., 2004; Rebillard et al., 
2007), cell entry/bioavailability of bioactive compounds (Adachi et al., 2007) and the 
localization of key proteins involved in immune response (Bene et al., 2004).  These 
findings indicate that exogenous lipids can no longer be ignored in the structures of 
membrane complexes, due to their ability to fine-tune and stabilize different signaling 
interfaces (Barrera et al., 2013; Levental et al., 2016; Lin et al., 2016).  According to this 
emerging picture, protein and lipid nanoclusters can be organized to form domains that 
are capable of facilitating Ras signaling events (Ariotti et al., 2014; Garcia-Parajo et al., 
2014; Zhou and Hancock, 2015).  For example, the formation of Ras dimers/nanoclusters 
is believed to be driven by cortical actin and/or proximal transmembrane proteins (Garcia-
Parajo et al., 2014).  This is noteworthy, because there is emerging evidence that drugs 
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and MTDB’s can attenuate Ras and EGFR activity by modulating nanocluster 
organization (Ariotti et al., 2014; Nussinov et al., 2014). Thus, we were interested in 
documenting the ability of n-3 PUFA to modulate clustering of membrane associated Ras 
proteins and the resultant attenuation of downstream oncogenic signaling in the intestine 
(Figure 3.6).  
  The spatial organization of Ras isoforms into non-overlapping nanometer scale 
domains on the plasma membrane facilitates the recruitment of Raf leading to ERK 
Figure 3.6.  Summary diagram highlighting n-3 PUFA suppression of oncogenic Ras 
mediated hyperproliferation and signaling through disruption of Ras spatiotemporal 
dynamics.  Incorporation of long chain n-3 PUFA into plasma membrane 
phospholipids generates heterotypic mixed clusters of H- and KRas proteins, 
disrupting their ability as nanoswitches to regulate ERK signaling.  This results in the 
suppression of oncogenic Ras driven phenotypes in the colon. 
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activation (Tian et al., 2007), creating a novel drug target (Cho and Hancock, 2013).  We 
observed that long chain n-3 PUFA selectively generate mixed clusters of K- and HRas 
(Figure 3.2G and Figure 3.4N), which ultimately attenuate ERK signaling (Figure 
3.3B&D and Figure 3.4E) and ameliorate Ras-driven phenotypes (Figure 3.1C-F and 
Figure 3.4A-D).  This is consistent with the ability of nonsteroidal anti-inflammatory 
drugs (Zhou et al., 2012) or actin disruption (Plowman et al., 2005; Zhou and Hancock, 
2015) to generate heterotypic mixed clusters, which compromise Ras signaling by 
reducing the physical engagement of downstream effectors.  Interestingly, DHA is known 
to affect actin dynamics which may partially explain the mechanism underlying the 
formation of heterotypic clusters (Hou et al., 2012; Kim et al., 2008; Turk et al., 2013).  
Furthermore the lipid composition of caveolae, which also regulate Ras lateral segregation 
(Ariotti et al., 2014), is modified by long chain n-3 PUFA (Ma et al., 2004b).  Specific 
lipid pools such as phosphatidylserine (PS), phosphatidic acid (PA), and 
phosphatidylinositol-4,5-bisphosphate (PIP2) are key structural components of Ras 
nanoclusters (Zhou and Hancock, 2017; Zhou et al., 2014).  Specifically, the lateral 
segregation and heterotypic mixing of H- and KRas is dependent on PS levels in the PM, 
where only optimal levels produce segregated clusters (Zhou et al., 2014).  Interestingly, 
we have previously demonstrated that dietary fish oil results in the incorporation of EPA 
and DHA into the acyl chains of PS and to a lesser extent PIP2 (Fan et al., 2003; Hou et 
al., 2012; Ma et al., 2004b).  This is noteworthy, because KRas plasma membrane 
localization and nanoclustering requires specific PS acyl chain species (Zhou et al., 2017), 
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raising the possibility that the altered PS acyl chain profile generated by dietary fish oil 
may underlie its effects on Ras nanoclustering.   
  The Drosophila genome encodes three members of Ras (Ras1, Ras2 and Ras3), of 
which Ras1 and Ras2 appear to share similarity with the carboxy terminus region of exon 
4B of human KRas (Shira Neuman-Silberberg et al., 1984).  Thus, we utilized a mutated 
form of Ras1 (RasV12) for our in vivo Drosophila functional studies. Interestingly, long 
chain n-3 PUFA suppressed Ras1-dependent oncogenic signaling and phenotypes in the 
fly, similar to the murine model. We therefore posit that long-chain n-3 PUFA may also 
generate heterotypic mixed clusters of Drosophila Ras isoforms (Figure 3.6).  However, 
further work is needed to address this possibility.  
  A common criticism facing the primary chemoprevention field is the fact the 
dietary bioactives, i.e., constituents in foods or dietary supplements other than those 
needed to meet basic human nutritional needs (Wallace et al., 2015), appear to be 
pleiotropic and affect diverse physiological processes including cell membrane 
structure/function (Turk et al., 2012), eicosanoid signaling (Fan et al., 2014; Serhan, 
2014), nuclear receptor activation (Pegorier et al., 2004), and inflammatory responses 
(Hou et al., 2015; Kim et al., 2010).  Our view is that this pleiotropic response of n-3 
PUFA in regard to cancer treatment is a benefit that counteracts the cellular 
heterogeneity of cancer.  From a chemoprevention perspective, we speculate that in 
addition to n-3 PUFA, other diet-derived amphiphilic compounds which accumulate in 
the colonic lumen, e.g., curcuminoids and polyphenols, may also alter plasma membrane 
organization and protein clustering (Chapkin et al., 2014; Fuentes et al., 2017; Hou et 
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al., 2016).  This may in part explain the chemoprotective effects attributed to the 
consumption of high levels of fruits and vegetables in the Mediterranean diet (Fazio and 
Ricciardiello, 2014).  Some supporting evidence documenting the interactive effects of 
membrane targeting bioactive compounds is provided by studies that demonstrate the 
combinatorial activity of curcumin and n-3 PUFA in gut stem cells during cancer 
initiation (Kim et al., 2016).   
  The complexity of cancer begins with the biological reprograming that occurs at 
the cellular level, but then scales exponentially with interactions taking place at the 
multi-cellular (McGranahan et al., 2015) and micro-environmental levels (Quail and 
Joyce, 2013).  Cancer stem cells (CSCs) maintain intratumor complexity and 
heterogeneity, making it an ideal therapeutic target (Dragu et al., 2015).  Importantly, n-
3 PUFA modulation of Ras nanoscale organization may be useful in targeting CSCs, 
since salinomycin, a recently established CSC inhibitor, targets KRas signaling and 
suppresses stemness (Najumudeen et al., 2016).  It is noteworthy, that DHA in part by 
altering lipid raft properties, has proven utility in inhibiting stem like properties that 
occur during epithelial mesenchymal transition (Tisza et al., 2014).  
  The differential effects of Ras isoforms on proliferation and tumor progression 
have largely been attributed to the HVR (Eisenberg et al., 2013). As such, colonic 
epithelial expression of oncogenic NRas, which lacks a polybasic repeat region but 
contains a palmitoylation site, fails to reproduce the growth properties imparted by 
oncogenic KRas (Haigis et al., 2008).  This in part explains why colonic tumors 
predominantly contain KRas mutations (Prior et al., 2012) and therefore most strategies 
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are geared toward targeting this isoform. However, the KRas transcript is alternately 
spliced and two products are produced, i.e., K(B)-Ras, the form normally identified as 
KRas, and K(A)-Ras (Plowman et al., 2006).  Recent work has demonstrated that both 
KRas isoforms are expressed in human tumor cells (Tsai et al., 2015), creating a need to 
therapeutically target both.  The K(A)-Ras isoform contains a dual targeting motif 
distinct from K(B)-Ras, that has a small polybasic domain and is palmitoylated 
(Eisenberg et al., 2013; Tsai et al., 2015).  Intriguingly, since n-3 PUFA can antagonize 
oncogenic HRas (Figure 3.3B) which is palmitoylated, it is possible that it would also 
inhibit K(A)-Ras signaling.  Further studies are needed to address this question.  
  As the technology used to monitor plasma membrane dynamics evolves 
(Klymchenko and Kreder, 2014; Kwiatek et al., 2014; Stone et al., 2017), it is becoming 
increasingly apparent that the actions of endogenous (Sousa et al., 2015; Zhou et al., 
2013) and exogenous (Machta et al., 2016; Zhang et al., 2016; Zhou et al., 2013) 
compounds are mediated in part through modifications of plasma membrane structure. 
In line with this, our novel observations support the feasibility of utilizing diet-related 
strategies that target plasma membrane organization to reduce oncogenic signaling and 
cancer risk (Escriba et al., 2015; Fuentes et al., 2017; Zalba and ten Hagen, 2017; Zhou 
et al., 2012). 
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3.4 Materials and methods 
3.4.1 Cell Culture 
  Conditionally immortalized Young Adult Mouse Colonic (YAMC) cells and 
YAMC-HRasG12V were originally obtained from R.H. Whitehead, Ludwig Cancer 
Institute (Melbourne, Australia).  YAMC cells (passages 14–19) were cultured under 
permissive conditions, 33°C and 5% CO2 in RPMI 1640 media (Mediatech, Manassas, 
VA) supplemented with 5% fetal bovine serum (FBS; Hyclone, Logan, UT), 2 mM 
GlutaMax (Gibco, Grand Island, NY), 5 μg/mL insulin, 5 μg/ml transferrin, 5 ng/ml 
selenious acid (Collaborative Bio-medical Products, Bedford, MA), and 5 IU/mL of 
murine interferon-γ (Roche, Mannheim, Germany). Flies were fed a chemically defined 
holidic diet (Piper et al., 2014) that allowed for precise control over all ingredients.   
 
3.4.2 Conditional Expression of UAS-Linked Transgenes 
The esgGal4 driver was combined with a ubiquitously expressed temperature-
sensitive Gal80 inhibitor (tubGal80ts).  The escargot construct drives expression in stem 
cells using the EGFR-Ras axis to maintain stemness and suppress differentiation (Jiang 
et al., 2011; Korzelius et al., 2014).  Crosses and flies were kept at 18°C (permissive 
temperature) and 5-day-old females were fed the test diets 5 days and then shifted to 29°C 
for 2 days to allow expression of the transgenes before analysis.  
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3.4.3 Immunostaining and microscopy 
Intact fly guts were fixed at room temperature for 20 min in 100 mM glutamic 
acid, 25 mM KCl, 20 mM MgSO4, 4 mM sodium phosphate, 1 mM MgCl2, and 4% 
formaldehyde. All subsequent incubations were performed using PBS, 0.5% BSA, 0.1% 
Triton X-100 at 4°C. The following primary antibodies were used: anti-phospho-Histone 
H3 (Millipore; 1:1000), anti-armadello (1:250 dilution), obtained from the Developmental 
Studies Hybridoma Bank. Fluorescent secondary antibodies were obtained from Jackson 
Immunoresearch. Hoechst dye was used to stain DNA. Confocal microscopy images were 
collected using a Nikon Eclipse Ti confocal system and processed using Nikon software 
and Adobe Photoshop. 
 
3.4.4 Western Blot Analysis of Intestinal Proteins 
Intact female guts were dissected in cold PBS and proteins extracted in Laemmli 
buffer, separated on 10% acrylamide gel and transferred according to standard procedures 
(Karpac et al., 2013). Antibodies directed against phospho-ERK (Cell Signaling 
Technology; 1:1,000), ERK total (Cell Signaling Technology; 1:1,000), β-actin (Cell 
Signaling Technology; 1:5,000 dilution) were used. Total protein extracts were pooled 
from 4 guts. 
 
3.4.5 Mouse genetics, diet and husbandry 
  The animal use protocol was approved by the University Animal Care Committee 
of Texas A&M University and conformed to NIH guidelines.  To generate an inducible 
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colonic targeted oncogenic KRas mouse model, CDX2P-CreERT2 mice (Jackson 
Laboratory, Stock No: 022390) were crossed with LSL-K-ras G12D mice (Jackson 
Laboratory, Stock No: 008179). Mice were housed in cages in a temperature- and 
humidity-controlled animal facility with a 12 h light/dark cycle and fed lab chow. For in 
vivo diet studies, mice were fed experimental diets containing either n-6 (control) or n-3 
PUFA for two weeks prior to tamoxifen injection (Figure 3.1A). Both diets contained 
20% (w/w) casein, 42% sucrose, 22% cornstarch, 6% cellulose, 3.5% AIN-76 mineral 
mix, 1% AIN-76 vitamin mix, 0.3% methionine, 0.2% choline, and 0.02% t-
butylhydroquinone (TBHQ). The n-6 diet contained 5% (w/w) corn oil (Dyets, Bethlehem, 
PA, #401150), and the n-3 diet contained 4% menhaden fish oil (Omega Pure, Houston, 
TX) and 1% corn oil. The diets were changed daily and contained TBHQ in order to 
prevent peroxidation (Fritsche and Johnston, 1988). Four weeks prior to termination, mice 
were injected once intraperitoneally (i.p.) with 200 mg/kg tamoxifen (Sigma-Aldrich, St. 
Louis, MO)(Feng et al., 2013) dissolved in corn oil or corn oil alone.  For the purpose of 
measuring rates of colonic cell proliferation, mice were injected i.p. with 50 mg/kg EdU 
(Life Technologies, A10044) 2 h prior to termination. At the time of euthanasia, colon 
tissue was flushed with PBS and the colon was processed to generate Swiss-rolls (Kim et 
al., 2016). Swiss rolls were subsequently fixed in 4% paraformaldehyde and embedded in 
paraffin.  
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3.4.6 In vivo measurement of crypt length and proliferation 
  For crypt length, tissue sections were stained with Alcian blue and imaged with a 
Leica Aperio CS2 digital pathology scanner. Crypt measurement was performed using 
ImageScope software. For cell proliferation assays, formalin-fixed paraffin-embedded 4 
μm colon sections were deparaffinized and rehydrated through graded ethanol washes. 
Cell proliferation in colonic crypts was measured using the Click-iT EdU Alexa Fluor 555 
Imaging kit (Life Technologies) as per the manufacturer’s instructions (Kim et al., 2016).  
Negative control slides were incubated without Click-iT Edu Alexa Fluor 555.   
 
3.4.7 Fluorescence lifetime imaging microscopy combined with fluorescence 
resonance energy transfer (FLIM-FRET) 
  YAMC cells were seeded at a density of 1x104 in cell imaging 8 chamber 
coverglass (Eppendorf, 0030742036) 24 h prior to fatty acid-BSA (50 uM) treatment. 
Following a 24 h incubation period, media without fatty acid was added and 
Lipofectamine 3000 was used to transiently transfect cells with plasmids of donor (GFP-
tagged protein) alone or co-transfected with FRET acceptors (Zhou and Hancock, 2015; 
Zhou et al., 2015).  FRET acceptors were RFP-tagged proteins of interest (GFP-: RFP-
plasmid at 1:3 ratio, 0.25 µg total plasmid per well). After 8 h in transfection media, cells 
were gently washed with PBS and incubated with complete media plus fatty acids for 40 
h.  Subsequently, cells expressing GFP-tagged protein alone or co-expressing both GFP-
tagged and RFP-tagged proteins were washed with PBS and fixed in 4% PFA for 15 min.  
After three washes in 1X PBS, HPBS was added to wells. Cells were imaged with a 1.3 
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numerical aperture 40x Plan-Fluor oil objective mounted on a wide field Nikon Eclipse 
microscope.  GFP was sinusoidally excited by a modulating 3-Watt 497 nm light-emitting 
diode (LED) at 40 MHz and fluorescence lifetime measured using a Lambert Instrument 
(Roden, The Netherlands) FLIM unit. At least 40 individual cells were imaged and 
lifetime (phase) values were pooled and averaged. Each experiment was replicated 2 
times.  Statistical analysis was performed using one-way ANOVA.  
  For Drosophila FLIM experiments, adult flies expressing GFP/RFP constructs in 
gut stem cells were dissected in PBS and fixed 20 min in 4% PFA prior to mounting in 
Mowiol medium.  Fields of view were scanned with an inverted LSM 780 microscope 
(Carl Zeiss Microimaging, Thornwood, NY) and a 1.4 numerical aperture 40× Plan 
Apochromat oil objective.  Two-photon excitation was provided by a Chameleon 
(Coherent Inc.) Ti:sapphire laser tuned to 900 nm. Emission events were registered with 
FastFLIM system (ISS, Champaign, IL).  Fluorescence lifetime images (256 × 256 pixels) 
were acquired with a pixel dwell time of 6.3 µs.  Lifetime of the imaged samples was 
determined with the frequency domain technique using the ISS VistaVision Suite version 
4.1.  At least 10 images were collected per treatment.  The percentage of the apparent 
FRET efficiency (Eapp) was calculated using the measured lifetimes of each donor-
acceptor pair (τDA) and the average lifetime of the donor only (τD) samples.  The formula 
employed was Eapp = (1-τDA/ τD) x 100% (Posada et al., 2016).  
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3.4.8 Immunofluorescence 
  Cells were seeded in cell imaging 8 chamber coverglass slides (Eppendorf, 
0030742036) and treated with select fatty acids (50 uM) for 72 h. Cells were subsequently 
starved (0.5% FBS, YAMC; 0% FBS, SW48) for 18 h in the presence of fatty acid, 
stimulated with EGF (25 ng/ml) (PeproTech, 315-09)  for 5 min and immediately fixed in 
ice cold 100% methanol.  Cells were incubated with primary phosphor-ERK (Cell 
Signaling Technology, #4370, dilution 1:200) antibody followed by Alexa Fluor 647-
conjugated secondary antibody (Jackson, #711-605-152, dilution 1:400). CellMaskTM 
Green Plasma Membrane Stain (ThermoFisher, #C37608, dilution 1:1000) was used to 
label the cells and Hoechst 33342 (ThermoFisher, #H3570, 5 ug/mL) to label the nucleus.  
Cells were imaged with a 1.3 numerical aperture 40x Plan-Fluor oil objective or 1.4 
numerical aperture 100x Plan-Apo oil objective mounted on a wide field Nikon Eclipse 
microscope using identical settings between samples.  For analysis, images were opened 
in ImageJ (NIH), converted to Tiff files and a custom macro was used to quantify average 
fluorescent intensity of pERK.  Briefly, green membrane stain was used to define a binary 
cell mask that was applied to pERK images.  Average fluorescent intensity of the mask 
images was subsequently recorded (Figure 3.7). 
 
3.4.9 Lipid extraction and fatty acid analysis 
  For assessment of dietary lipid incorporation into membrane phospholipids, total 
lipids were extracted from isolated mouse crypts (Ma et al., 2004b) and at least 28 
dissected drosophila guts per treatment with 2:1 (v/v) chloroform-methanol as previously 
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described (Fan et al., 2003). Total phospholipids were subsequently separated by thin-
layer chromatography with 90:8:1:0.8 (v/v/v/v) chloroform-methanol-acetic acid-water.  
After transesterification using methanolic HCl, fatty acid methyl esters were quantified by 
capillary gas chromatography-mass spectrometry (Fan et al., 2003). 
 
Figure 3.7.  Quantitative image based analysis of pERK.  (A) YAMC-HRasG12V or 
(E) Sw48-KRasG12D cells were grown in 8-well glass bottom dishes and treated with 
50 uM indicated fatty acid for 72 h.  Cells were starved (0.5% FBS, YAMC; 0% FBS, 
SW48) for 18 h in the presence of fatty acid and subsequently stimulated with EGF 
(25 ng/ml) for 5 min.  Cells were then immediately fixed in ice cold 100% methanol. 
(A, B) merged DIC and DAPI images; (B, F) CellMaskTM Green Plasma Membrane 
Stain was used to define (C, G) binary whole cell masks, which was used to create 
(D, H) masked images of pERK. Scale bar = 20 µM. 
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 CHAPTER IV  
LONG CHAIN n-3 FATTY ACIDS DISRUPT COLINIC CELL 
MACROPOINOCYTOSIS 
4.1 Introduction  
n-3 PUFA (DHA and EPA) found in fish oil, are often described as 
chemoprotective with respect to colon cancer (Hall et al., 2008). The mechanism 
underlying this association is not well resolved. Approximately 30-50% of colorectal 
cancers contain KRas mutations, which confer resistance to standard therapy (Stephen et 
al., 2014), and reduce survival (Phipps et al., 2013).  Unfortunately, attempts to directly 
target Ras have repeatedly failed (Phipps et al., 2013), leading to strategies developed 
that target identified dependencies such as unique metabolic requirements (Cox et al., 
2014). Macropinocytosis is the cellular process of engulfment of extracellular 
components driven by dynamic changes in plasma membrane lipids and cytoskeletal 
proteins (Bohdanowicz and Grinstein, 2013; Levin et al., 2015; Lim and Gleeson, 2011), 
which has been identified as the delivery route for the fuel that feeds these cancers 
(Commisso et al., 2013; Salloum et al., 2014).  Since we previously demonstrated that n-
3 PUFA modify plasma membrane organization through a cytoskeletal mediated process 
(Chapkter II), we sought to determine if the clinically relevant, cytoskeletal mediated 
process of macropinocytosis would be inhibited. 
By using colonic cell lines and in vivo transgenic models, we show that n-3 
PUFA attenuate macropinocytosis. Furthermore, we elucidate a mechanism by which 
expression of oncogenic KRas results in an increase in plasma membrane rigidity which 
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is maintained by increased plasma membrane free cholesterol levels.  Normalization of 
plasma membrane rigidity through incorporation of n-3 PUFA or cholesterol depletion 
results in an attenuation of macropinocytosis. These findings demonstrate how n-3 
PUFA act as chemoprotective agents, and identify plasma membrane rigidity as a 
pharmacological target for oncogenic KRas driven colon cancers. 
 
4.2 Results 
4.2.1 Macropinocytosis is attenuated by n-3 PUFA 
Previous experiments demonstrated that long chain n-3 PUFA reduced the 
rigidity of live cell plasma membranes (Figure 2.2), and disrupted membrane-
cytoskeletal connections indirectly (Figure 2.4) or directly through attenuation of Rac1 
and Cdc42 (Turk et al., 2013).  Therefore we sought to determine the effect of n-3 PUFA 
on a cellular process which depends on plasma membrane-cytoskeletal interactions, i.e. 
macropinocytosis (Fujii et al., 2013; Grimmer et al., 2002; Maekawa et al., 2014). 
 Macropinocytosis was determined by an imaging based assay which relies on the 
identification and quantification of internalized fluorescently labeled dextrans 
(Commisso et al., 2014).  When stimulated with epidermal growth factor (EGF), YAMC 
cells exhibit an increase in macropinocytosis which is attenuated by DHA and EPA (Fig 
4.1A & B).  Importantly, fat-1 mouse derived crypts also exhibited reduced 
macropinocytosis (Fig 4.1C & D).  
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 Since EGF mediated Ras activation is linked to macropinocytosis and DHA is 
known to disrupt the EGFR-Ras axis (Ma et al., 2004b; Rogers et al., 2010; Turk et al., 
2012), we sought to determine if n-3 PUFA effects on macropinocytosis is independent 
of Ras activation. For this purpose, we utilized a genetically encoded biosensor that 
reports on Ras activation by surveying the temporal GEF/GAP activity in H- and K-Ras 
domains (Fukano et al., 2007; Mochizuki et al., 2001). These Ras-Raichu probes exhibit 
high FRET efficiency when in the GTP bound state (Mochizuki et al., 2001).  Only 
Figure 4.1.  Macropinocytosis is attenuated by n-3 PUFA. Macropinocytosis uptake 
was determined by incubating (A) YAMC cells or (C) colonic crypts with 
fluorescently labeled dextrans for 15 minutes with or without the presence of EGF 
(100 ng/ml). (B) Quantification of relative macropinocytotic index of cells incubated 
with 50 uM FA  for 72 hrs. Data represent mean macropinocytosis uptake from each 
field of view (FOV, n= Un –EGF 10, Un +EGF 33, LA 30, EPA 34 and DHA 32) 
from 2 independent experiments. (D) Colonic crypts isolated from fat-1 mice show 
reduced macropinocytosis. Data represent mean macropinocytosis per crypt from at 
least 28 crypts from 2 animals per genotype. Statistical significance between 
treatments as indicated by different letters (P<0.05) was examined using one-way 
ANOVA and uncorrected Fisher’s LSD tests or indicated by (*P < 0.005) was 
determined using an unpaired t-test. 
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DHA was able to attenuate Ras activation (Figure 4.2A-C) in both H- and K-Ras 
domains, indicating a Ras independent effect of EPA to attenuate EGF stimulated 
macropinocytosis. Furthermore, EGF independent constitutive macropinocytosis driven 
Figure 4.2.  Long chain n-3 PUFA attenuation of macropinocytosis is independent of 
EGF-mediated Ras activation status. (A) Spatiotemporal activation of Ras was 
determined by monitoring activation of Ras-Raichu FRET biosensors targeted to (B) 
K- or (C) H-Ras domains. (D) Non-EGF stimulated oncogenic Ras driven 
macropinocytosis was determined in YAMC cells expressing oncogenic HRasG12V 
proteins incubated with 50 uM FA for 72 hrs. Data represent mean ± SEM FRET 
ratio for each cell, (B) n=Un 9, LA 11, EPA 11 and DHA 9 from 1 experiment, (C) 
n=Un 26, LA 10, EPA 10 and DHA 22 from 2 independent experiments. (D) Data 
represent mean macropinocytosis uptake from each field of view (FOV, n=Un 20, 
LA 15, EPA 18 and DHA 16). Statistical significance between treatments as 
indicated by different letters (P<0.05) was examined using one-way ANOVA and 
uncorrected Fisher’s LSD tests. 
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by oncogenic HRasG12V (Commisso et al., 2013; D’Abaco et al., 1996) was attenuated 
by both EPA and DHA (Figure 4.2D).  
 
4.2.2 Cholesterol depletion reduces membrane order and macropinocytosis 
Since n-3 PUFA disrupt membrane order and macropinocytosis, we sought to 
determine if there is a relationship between membrane order and macropincoytosis. As a 
means of pharmacologically disrupting membrane order, YAMC cells were treated with 
several doses of MBCD to deplete cholesterol (Figure 4.3A&B), reduce membrane 
order (Figure 2.1), and subsequently attenuate macropincoytosis (Figure 4.3C).  
 
Figure 4.3.  Methyl-β-cyclodextrins depletes cholesterol, reduces membrane order 
and attenuates macropinocytosis in YAMC cells. YAMC cells were pre-incubated 
with the indicated dose of MβCD (0-10 mM) for 30 min followed by (A) staining 
with filipin to determine (B) cholesterol, or incubated with EGF (100 ng/ml, 15min) 
and FITC-Dextran to determine macropinocytosis. (B) Data represent mean filipin 
intensity from each FOV from n= (MβCD 0mM 4, MβCD 1mM 3, MβCD 5mM 3, 
MβCD 10mM 4). (C) Relative macropinocytotic index from each FOV from n= 
MβCD 0 mM 4, MβCD 1 mM 7, MβCD 5 mM 7, MβCD 10 mM 8) with ~10 cells 
per FOV. Statistical significance of differences between untreated control and treated 
cells were examined using one-way ANOVA tests (n.s., not significant; *P < 0.05; 
**P < 0.01). 
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4.2.3 Oncogenic Ras increases membrane order through increased cholesterol which 
facilitates macropinocytosis 
Oncogenic Ras expressing cells constitutively upregulate macropinocytosis to 
provide fuel necessary for metabolic reprogramming (Commisso et al., 2013; Salloum et 
Figure 4.4.  Oncogenic KRasG12D expressing SW48 cells exhibit increased 
macropinocytosis. SW48 wild type and KRasG12D expressing cells were incubated 
with fluorescently (FITC) labeled dextran (70 kDa, 1 mg/mL) for 30 minutes, 
trypsinized, fixed in PFA, and assayed using an imaged based flow cytometry system 
(Amnis FlowSight). (A) Representative bright field and FITC image.  (B) 
Quantification of macropinocytosis normalized to wild type control. Data represent 
mean ± SEM for at least 1,000 cells. Statistical significance between wild type 
control and KRasG12D expressing cells (*P < 0.0001) was determined using an 
unpaired t-test. 
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al., 2014).  Activation of PI3K, PLC, and Rac1 play a role in this process (Bar-Sagi and 
Feramisco, 1986; Porat-Shliom et al., 2007; Walsh and Bar-Sagi, 2001), however the 
contribution of plasma membrane organization to this process has not been established.  
Similarly, phagocytosis, although distinct from macropinocytosis, is a cellular 
internalization process which requires coordinated membrane-cytoskeletal dynamics and 
maintenance of rigid membrane domains (Magenau et al., 2011).     
Isogenic cell lines expressing oncogenic H- or K-Ras showed increased 
macropinocytosis under basal conditions vs parental cells with wild type Ras (Figure 
4.4). SW48 cells expressing oncogenic KRas exhibited increased PM rigidity (Figure 
4.5), likely driven by an increase in plasma membrane free cholesterol (Figure 4.6). 
Importantly these results are not an artifact of overexpression as these cell lines are 
engineered to express endogenous levels of oncogenic KRas (Hammond et al., 2015). 
Figure 4.5.  Oncogenic KRasG12D expressing SW48 cells exhibit increased 
membrane order. SW48 wild type and KRasG12D expressing cells were stained with 
Di-4-aneppdhq (5uM) and immediately imaged by confocal microscopy.  
(A) Representative GP images. (B) Quantification of membrane order. Values are 
expressed as delta GP (sample – control). Data represent mean ± SEM for at least 15 
field of views containing at least 150 cells from 2 independent experiments. 
Statistical significance between wild type control and KRasG12D expressing cells 
(*P < 0.001) was determined using an unpaired t-test. 
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 We subsequently confirmed our in vitro results (SW48 cells) utilizing an in vivo 
mouse model in which oncogenic KRas is inducibly targeted to the colon as described 
previously (Feng et al., 2011, 2013) (Figure 3.1B). Mice were fed a diet containing corn 
oil (n-6 PUFA control) or fish oil (Tables 3.1 & 3.2) for 2 wks prior to tamoxifen 
induction of oncogenic KRas and maintained for an additional 11-13 weeks. As we 
observed in vitro, primary oncogenic expressing colonic crypts from mice fed a corn oil 
diet exhibited increased macropinocytosis (Figure 4.7), membrane order (Figure 4.8) 
and cholesterol  (Figure 4.9) vs corn oil injected wild type control crypts (Figure 4.7-
4.9). Importantly, the macropinocytosis and membrane order phenotype was reversed to 
Figure 4.6.  Oncogenic KRasG12D expressing SW48 cells exhibit increased 
cholesterol. SW48 wild type and KRasG12D expressing cells were stained with 
filipin III (50 ug/ml) for 45 minutes on ice in the dark, followed by imaging by wide 
filed microscopy. (A) Representative DIC and filipin intensity images. (B) 
Quantification of filipin intensity. Values are normalized to wild type control. Data 
represent mean ± SEM for at least 5 fields of views containing at least 60 cells. 
Statistical significance between wild type control and KRasG12D expressing cells 
(*P < 0.01) was determined using an unpaired t-test. 
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Figure 4.7.  Dietary fish oil ameliorates oncogenic KRas mediated macropinocytosis 
in isolated colonic crypts.  Mice were fed experimental diets for 2 weeks prior to 
induction of oncogenic KRasG12D in the colon by injection of tamoxifen (200 
mg/kg, 1X). Isolated colonic crypts were incubated with FITC-Dextran (1mg/ml) and 
deep red plasma membrane stain for 30 minutes, fixed and imaged with a 20x oil 
objective. A) Representative crypt used to define regions of interest. B) Quantitative 
macropinocytosis data.  Bars represent mean ± SEM from number of crypts indicated 
in each bar, from at least four mice in each group normalized to the corn oil, no 
Tamoxifen control. Statistical significance between treatments as indicated by 
different letters (P<0.05) was examined using Tukey's multiple comparisons test.   
Figure 4.8.  Dietary fish oil ameliorates oncogenic KRas mediated membrane order 
in isolated colonic crypts.  Mice were fed experimental diets for 2 weeks prior to 
induction of oncogenic KRasG12D in the colon by injection of tamoxifen (200 
mg/kg, 1X). After 10-12 weeks post tamoxifen injection, isolated colonic crypts were 
stained with Di-4-aneppdhq (5 uM) and immediately imaged with a 20x oil objective. 
A) Example field of view containing multiple crypts. B) Representative crypt used to 
define region of interest. C) Quantitative membrane order data. Bars represents mean 
± SEM from the number of crypts indicated in each bar, from at least four mice in 
each group, normalized to corn oil no Tamoxifen control. Statistical significance 
determined by Tukey's multiple comparisons test. 
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basal wild type levels by the dietary administration of fish oil (Figure 4.7 & 4.8). 
Interestingly, although fish oil treatment reduced membrane order, it did not 
significantly reduce plasma membrane free cholesterol in the tamoxifen injected 
oncogenic KRas expressing group (Figure 4.9).  In a subset of mice we further verified 
the increase in membrane order and membrane cholesterol at 20 weeks post oncogenic 
KRas induction.  This analysis was performed using imaged based flow cytometry of 
isolated single cells from primary crypts (Figure 4.10).  In this set of experiments, 
dietary fish oil treatment reduced membrane order and cholesterol levels relative to the 
oncogenic KRas expressing corn oil control (Figure 4.10).  
 
Figure 4.9.  Dietary fish oil ameliorates oncogenic KRas mediated increase of free 
cholesterol in isolated colonic crypts.  Mice were fed the experimental diets for 2 
weeks prior to induction of oncogenic KRasG12D in the colon by injection of 
tamoxifen (200 mg/kg, 1X).  After 11-13 weeks, isolated colonic crypts were fixed 
and stained with filipin III (50 ug/ml) for 45 minutes on ice in the dark, imaged with 
a 10x 0.3 NA phase objective. Representative (A) phase and (B) filipin field of view. 
(C) Representative region of interest (dashed green) defining crypts in filipin image. 
D) Quantitative free cholesterol data. Bars represent mean ± SEM from the number 
of crypts indicated in each bar in at least four mice per each group, normalized to 
corn oil, no Tamoxifen control. Statistical significance determined by Tukey's 
multiple comparisons test. 
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4.3 Discussion 
In this work we investigated the relationship between plasma membrane rigidity 
and macropinocytosis during exogenous treatment with long chain n-3 PUFA and the 
induction of oncogenic KRas. We demonstrate for the first time live cell plasma 
membrane rigidity and macropinocytotic capacity are highly correlated.   
 Long chain n-3 PUFA attenuated EGF stimulated colonic cell macropinocytosis 
in vitro an in vivo (Figure 4.1). Importantly this was not a direct effect of DHA on EGF 
activation (Ma et al., 2004b; Rogers et al., 2010; Turk et al., 2012), since EPA which 
Figure 4.10.  Dietary fish oil ameliorates oncogenic KRas mediated increase in 
membrane order and cholesterol in single cells from isolated colonic crypts.  Mice 
were fed the treatment diets for 2 weeks prior to induction of oncogenic KRasG12D 
in the colon by injection of tamoxifen (200mg/kg, 1X). Single cells were generated 
from colonic crypts after 20 weeks and stained with Di-4-aneppdhq (1 uM) or fixed, 
stained with filipin (50 ug/ml, 45 min) and imaged on the Flowsight imaging system. 
A) Representative image and B) quantitative membrane order data. C) Representative 
images and D) quantitative free cholesterol (filipin) data.  Bars represent mean ± 
SEM from at least 10,000 events from two mice in each group, normalized to corn 
oil, no Tamoxifen control. Statistical significance determined by Tukey's multiple 
comparisons test. 
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does not affect EGF mediated Ras activation (Figure 4.2), also attenuated 
macropinocytosis (Figure 4.1A).  Further evidence was provided by n-3 PUFAs 
attenuation on non-EGF stimulated macropinocytosis (Figure 4.2D) in YAMC cells 
expressing a HRasG12V mutation (Commisso et al., 2013; D’Abaco et al., 1996). 
 Oncogenic Ras expression in vivo and in vitro resulted in an increase of 
macropinocytosis (Figure 4.4 & 4.7) accompanied by an increase in membrane rigidity 
(Figure 4.5 & 4.8) triggered by plasma membrane free cholesterol accumulation 
(Figure 4.6 & 4.9).  Reducing membrane rigidity through cholesterol depletion (Figure 
4.3) or membrane incorporation with n-3 PUFA reduced macropinocytosis (Figure 4.7 
& 4.8). Further work will be required to probe the exact mechanism underlying the 
ability of oncogenic KRas to upregulate free cholesterol.  A possible explanation for the 
increase in cholesterol may involve the cholesterol transporter ABCA1, which is down 
regulated by oncogenic Ras (Smith and Land, 2012) and is known to alter plasma 
membrane biophysical properties (Zarubica et al., 2009), Rac1 activation (Pagler et al., 
2011) and affect endocytosis (Zarubica et al., 2009). 
Taken together, our data indicate that exogenous treatments that reduce plasma 
membrane rigidity may prove useful in attenuating oncogenic KRas mediated 
macropinocytosis. Establishing a role of long chain n-3 PUFA in colon cancer 
prevention would have a major translational impact because these dietary bioactives are 
safe, well tolerated, relatively inexpensive, and provide additional health benefits, such 
as reduction in mortality (Bell et al., 2014).  In addition, the ingestion of long chain n-3 
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PUFA in combination with other agents with complementary anti-tumor action may 
improve their efficacy in colon cancer prevention/therapy. 
 
4.4 Materials and methods 
4.4.1 YAMC Cell Culture 
  Conditionally immortalized Young Adult Mouse Colonic (YAMC) cells and 
YAMC-HRasG12V were originally obtained from R.H. Whitehead, Ludwig Cancer 
Institute (Melbourne, Australia).  YAMC cells (passages 14–19) were cultured under 
permissive conditions, 33°C and 5% CO2 in RPMI 1640 media (Mediatech, Manassas, 
VA) supplemented with 5% fetal bovine serum (FBS; Hyclone, Logan, UT), 2 mM 
GlutaMax (Gibco, Grand Island, NY), 5 μg/mL insulin, 5 μg/ml transferrin, 5 ng/ml 
selenious acid (Collaborative Bio-medical Products, Bedford, MA), and 5 IU/mL of 
murine interferon-γ (Roche, Mannheim, Germany). Isogenic SW48 parental and 
KRasG12D cells (Horizon Discovery) were maintained at 33°C and 5% CO2 in McCoy’s 
5A medium supplemented with 10% FBS.  Select cultures were treated for 72 h with 50 
μM fatty acid [linoleic acid (LA, 18:2n6), arachidonic acid (AA, 20:4n6), 
eicosapentaenoic acid (EPA, 20:5n3) or docosahexaenoic acid (DHA, 22:6n3); NuChek, 
Elysian, MN] complexed with fatty acid free bovine serum albumin (BSA). 
 
4.4.2 Macropinocytosis Assay  
Macropinocytosis assay was performed as described previously (Commisso et 
al., 2014).  Briefly, YAMC cells were treated with FA were serum starved (0.5%, FBS) 
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for 12-18 hours, incubated with 0.5 mg/mL TMR-Dextran and stimulated with EGF (100 
ng/ml) for 15 minutes at 33°C and fixed in 4% PFA, and mounted with ProLong 
Diamond with DAPI (Life Technologies).  
 
4.4.3 Ras-Raichu FRET Biosensor Ratiometric Imaging and Quantification 
YAMC cells were untreated or treated with indicated PUFA for 24 hours then 
transfected with plasmid encoding H-Ras (Raichu-141x) and K-Ras (Raichu-124x) 
targeted Ras-Raichu biosensors (Mochizuki, 2001). Cells were then treated an additional 
48 hours and starved in Phenol free-RPMI (0.5%, FBS), 1% Glutamax, 1% Pen/Strep, 
with IFN-y, no ITS for 4 hours before stimulation with EGF (25 ng/ml).  Images were 
acquired with a Nikon wide field microscope equipped with a 1.4 numerical aperture 
63× Plan Apochromat oil objective, every 2 minutes, starting 10 minutes before EGF 
stimulation and ending 30 minutes after.  Images were processed and FRET ratio 
determined as described previously (Aoki, 2009).  
 
4.4.4 Mouse genetics, diet and husbandry 
Animal use protocols were approved by the University Animal Care Committee 
of Texas A&M University and conformed to NIH guidelines.  To generate an inducible 
colonic targeted oncogenic KRas mouse model, CDX2P-CreERT2 mice (Jackson 
Laboratory, Stock No: 022390) were crossed with LSL-K-ras G12D mice (Jackson 
Laboratory, Stock No: 008179). Mice were housed in cages in a temperature- and 
humidity-controlled animal facility with a 12 hour light/dark cycle and fed lab chow. For 
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in vivo diet studies, mice were fed experimental diets containing either n-6 (control) or 
n-3 PUFA for two weeks prior to tamoxifen injection (Figure 3.1A). Both diets 
contained 20% (w/w) casein, 42% sucrose, 22% cornstarch, 6% cellulose, 3.5% AIN-76 
mineral mix, 1% AIN-76 vitamin mix, 0.3% methionine, 0.2% choline, and 0.02% t-
butylhydroquinone (TBHQ). The n-6 diet contained 5% (w/w) corn oil (Dyets, 
Bethlehem, PA, #401150), and the n-3 diet contained 4% menhaden fish oil (Omega 
Pure, Houston, TX) and 1% corn oil. Diets were changed daily and contained TBHQ in 
order to prevent peroxidation (Fritsche and Johnston, 1988). At indicated times prior to 
termination, mice were injected once intraperitoneally (i.p.) with 200 mg/kg tamoxifen 
(Sigma-Aldrich, St. Louis, MO)(Feng et al., 2013) dissolved in corn oil or corn oil alone 
(control).   
 
 
 
 
 
 
 
 
CHAPTER V  
SUMMARY AND CONCLUSIONS 
5.1 Summary 
With respect to all human malignancies, 35% are linked directly to diet and an 
additional 14-20% to obesity (Coussens et al., 2013).  Consistent with these data, cancer 
risk can be lowered by 36% when humans adhere to healthy dietary principles, e.g., high 
intake of fruits, vegetables, and whole grains and low meat consumption (Ford et al., 
2009).  Therefore, it is imperative that health professionals make sound dietary/lifestyle 
recommendations.  However, even though there are many observational/epidemiological 
studies linking diet and cancer risk, the association cannot be easily explained 
mechanistically.  Therefore, establishing a role for cancer dietary chemoprevention 
approaches that are generally free of safety problems intrinsic to drugs administered over 
long periods of time would have a major translational impact in cancer prevention and 
patient survivorship (Ford et al., 2009; Lien, 2009). In view of this need, our long-term 
goal is to better understand the molecular mechanisms modulating intestinal epithelial 
cell responses to MTDB’s. 
Notably, we have demonstrated that dietary n-3 PUFA modify colonocyte plasma 
membrane biophysical properties in vitro and in vivo, in a manner that is dependent on 
cytoskeletal interactions (Figures 2.2 & 2.5). In addition, a very similar phenotype was 
observed in activated CD4+ T cells (Figure 2.6). Furthermore, we documented for the 
first time that membrane phase separation is induced following high dose n-3 PUFA in 
human CD4+ T cell GPMVs (Figure 2.6).    
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We also documented the ability of n-3 PUFA to reshape the nanoscale 
architecture of Ras nanoclusters. Esterification of n-3 PUFA into plasma membrane 
phospholipids in vitro (Table 3.3) resulted in the formation of heterotypic mixed clusters 
of H- and KRas (Figure 3.2 & 3.4).  These clusters signaled through ERK less 
efficiently (Figure 3.3), resulting in the attenuation of oncogenic Ras driven phenotypes 
in both murine (Figure 3.1) and Drosophila (Figure 3.4) models.  Additionally, we 
found that a reduction in plasma membrane rigidity associated with n-3 PUFA 
incorporation (Figure 4.2) or cholesterol depletion (Figure 4.3), attenuated colonic cell 
macropinocytosis. This is highly relevant because macropinocytosis has recently been 
identified as a dependency of oncogenic Ras driven tumors (Commisso et al., 2013).  
Using isogenic cell lines and in vivo mouse models, we then determined that oncogenic 
KRas increases plasma membrane rigidity via upregulation of plasma membrane free 
cholesterol levels (Figure 4.5, 4.6, 4.8-4.10).  The ability of oncogenic KRas to increase 
macropinocytosis was dependent on the biophysical rigidification of the membrane 
imparted by the accumulation of cholesterol, as n-3 PUFA, which fluidized the 
membrane (Figure 4.8), attenuated macropinocytosis (Figure 4.7) but did not 
significantly alter cholesterol levels (Figure 4.9). These findings suggest that the 
dietary/pharmacological targeting of plasma membrane rigidity may suppress oncogenic 
KRas driven colonic tumors. 
5.2 Future directions 
The data presented herein contribute to the mechanistic understanding of how n-3 
PUFA influence Ras mediated phenotypes, however many questions still remain 
regarding the precise impact of n-3 PUFA on cellular function.  Furthermore, this 
research raises the question; are the chemoprotective effects attributed to other dietary 
MTDB’s also linked to the modulation of plasma membrane hierarchical organization? 
5.2.1 Plasma membrane cytoskeleton interaction 
Our data demonstrate that the effect of n-3 PUFA on membrane organization is 
in part mediated by the actin cytoskeleton (Figure 2.2 & 2.5). Therefore, it is important 
to directly assess the effects on n-3 PUFA on the cytoskeleton.  The  cytoskeletal cortical 
actin mesh influences plasma membrane organization (Alvarez-Guaita et al., 2015; Dinic 
et al., 2013; Garcia-Parajo et al., 2014; Owen et al., 2012b).   Importantly, this cortical 
actin mesh network structure is modulated at the sub-resolution scale (~1-20 nm), 
therefore conventional microscopy techniques may not provide sufficient resolution.   
Recent super-resolution techniques such as SIM (~50-100 nm) (Rego et al., 2012) are 
approaching the necessary resolution and others PALM/STORM (10-20 nm) (Xu et al., 
2012) may achieve the resolution necessary to determine an effect of DHA on the 
cytoskeleton. Other techniques such as electron microscopy (~1 nm) provide sufficient 
resolution but require extensive experience in sample preparation (Henson et al., 2015; 
Morone, 2010; Morone et al., 2006).  
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Further insight into the precise mechanism of n-3 PUFA action can be elucidated 
through experiments involving pharmacological modulation of filamentous actin. As an 
example, the cytoskeletal stabilizing agent jasplakinolide has been shown to stabilize 
rigid membrane domains even after the addition of cholesterol disrupting agents 
(Chichili et al., 2010). Similar experiments can be performed with latrunculin B, 
however the interpretation is more difficult since disruption of f-actin can increase or 
decrease membrane order depending on the cell type (Alvarez-Guaita et al., 2015; Dinic 
et al., 2013).  
What is the mechanism by which a membrane lipid containing n-3 PUFA inhibit 
the cytoskeleton?  A possible explanation involves PIP2, which is reduced by n-3 PUFA 
(Hou et al., 2012). This is mechanistically relevant because PIP2 is highly enriched in 
lipid raft domains (Chierico et al., 2014; Zhou et al., 2014).  In addition, sequestering 
Figure 5.1.  Putative model for the effect of DHA on membrane order.  Actin-
binding proteins (ABP) bind PIP2 and F-actin, which stabilize membrane lipid order.  
DHA reduces levels of PIP2, which reduces the interaction of filamentous actin with 
the plasma membrane, thereby reducing lipid order.  Lo, liquid order; Ld, liquid 
disordered. 
PIP2 (using neomycin) reduces co-clustering of Liquid ordered (rigid) domain probes, 
indicating reduced membrane order (Chichili et al., 2010).    
PIP2 links to the cytoskeleton by the adaptor protein ezrin (Bosk et al., 2011; 
Logan and Mandato, 2006; Shabardina et al., 2016). Activated ezrin colocalizes with f-
actin, acting as an adaptor protein linking the plasma membrane and cytoskeleton (Liu et 
al., 2013).  Recently it was demonstrated the PIP2 binding to ezrin increases membrane 
tension (Braunger et al., 2014) which is important for maintaining clustering of liquid 
ordered domains (Chichili et al., 2010).  Since PIP2 binding is a prerequisite for 
phosphorylation and activation of ezrin (Fievet et al., 2004), and PIP2 levels are reduced 
in cells isolated from mice enriched with n-3 PUFA (Hou et al., 2012), we have 
hypothesized that DHA reduces membrane order by altering PIP2 spatiotemporal 
dynamics, thereby modulating ezrin phosphorylation and reducing cytoskeletal 
attachment (Figure 5.1).  This will be the subject of future experiments in the Chapkin 
lab. 
5.2.2 Nanocluster mediating lipids 
Our data indicate that n-3 PUFA modify the spatial organization of Ras 
nanoclusters, resulting in mixing of truncated forms of H- and KRas (Figure 3.2G and 
Figure 3.4N).  However, the question regarding how n-3 PUFA mislocalize Ras 
nanoclusters still remains to be addressed.  Insight to this question may be gained 
through monitoring the spatial organization of Ras isoforms in relation to specific lipid 
pools of phosphatidylserine (PS), phosphatidic acid (PA), and PIP2.  These lipids are key 
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structural components of Ras nanoclusters (Zhou and Hancock, 2017; Zhou et al., 2014).  
Specifically, the lateral segregation and heterotypic mixing of H- and KRas is dependent 
on PS levels in the plasma membrane, where only optimal levels produce segregated 
clusters (Zhou et al., 2014).  In addition, future work will be necessary to determine if 
other dietary compounds that modify membrane organization (Fuentes et al., 2017) also 
modulate Ras cluster formation. 
5.2.3 Cholesterol modulation by oncogenic Ras 
We documented the ability of oncogenic Ras to rigidify the plasma membrane 
through increased plasma membrane free cholesterol (Figure 4.5, 4.6, 4.8-4.10).  Further 
work is necessary to determine the mechanism by which oncogenic Ras increases 
plasma membrane free cholesterol.  A possible explanation for the increase in 
cholesterol may involve the cholesterol transporter ABCA1, who’s down regulation by 
oncogenic Ras (Smith and Land, 2012) facilitates rapid tumor growth (Gabitova et al., 
2015).  ABCA1 expression results in a reduction of plasma membrane cholesterol which 
reduces the rigidity of the plasma membrane (Zarubica et al., 2009).  In fact, the 
regulation of plasma membrane cholesterol and membrane order through ABCA1 is an 
intrinsic cell process utilized by crowded cells (Frechin et al., 2015).  
5.2.4 Impact of other dietary bioactives on membrane organization 
The two leaflets of the plasma membrane lipid bilayer each have unique 
interactions. The cytofacial (inner) leaflet interacts directly with the actin 
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cytoskeleton. The exofacial (outer) leaflet is the site for ligand-receptor interactions, 
as well as glycosylated protein interactions. Several classes of MTDBs, because of 
size, hydrophobic/hydrophilic interactions or steric hindrances, do not readily 
intercalate or incorporate into the phospholipid membrane.  Examples, include high 
oligomer polyphenols, which do not penetrate the membrane but nevertheless alter 
membrane organization (Erlejman et al., 2004; Fuentes et al., 2017; Verstraeten et al., 
2013) (Figure 5.2). For example, although intact procyanidins have some systemic 
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Figure 5.2.  Putative mechanism by which bioactive dietary molecules interact with 
the plasma membrane. This model depicts plasma membrane structure with long-
chain n-3 polyunsaturated fatty acids (PUFA) (red lines) incorporated into 
phospholipids, curcumin (yellow spheroids) intercalating between phospholipids and 
polyphenols (green shapes) interacting with the exofacial leaflet. The presence of 
either molecule may modulate plasma membrane-dependent cellular signaling by 
disrupting lipid-lipid and lipid-protein interactions.     
biological activity, they are poorly absorbed and pass into the distal intestine (colon) where 
they are further metabolized by gut microbes to generate monomeric catechin and 
epicatechin compounds along with other dimers-hexamer species (Choy et al., 2013; 
Verstraeten et al., 2015; Williamson and Manach, 2005).  These microbial metabolites can 
interact with the apical membranes of colonic epithelial cells. Additional studies are 
needed to elucidate the mechanisms by which MTDBs and select drugs interact at the 
membrane level. 
5.3 Conclusion 
In regard to colon cancer, n-3 PUFA are believed to be chemoprotective. 
However, the mechanisms underlying the effects of these pleiotropic molecules have not 
been elucidated. By characterizing the effects of n-3 PUFA on plasma membrane 
protein/protein interactions, our research findings have contributed to the mechanistic 
understanding as to how biophysical alterations to plasma membrane organization can 
attenuate oncogenic Ras signaling and phenotypes.  
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